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Glycogen synthase kinase-3 (GSK-3), a serine/threonine kinase, is originally 
implicated in phosphorylating and inactivating glycogen synthase. Two isofoms, 
termed GSK-3a and GSK-3p, which generate a 51 and a 47KDa protein, 
respectively, are found in mammals. GSK-3 is now known to be a multi-substrate 
protein kinase, and expressing in different tissues. To understand the genetic 
organization and its regulation, the promoter of GSK-3a was isolated and the 
expression studies on both isoforms were carried out. 
GSK-3a promoter was isolated by 3 approaches: (1) 5'RACE, (2) PromoterFinder 
DNA walking method, and (3) from YAC clone 33A9D. Several fragments isolated 
by 5'RACE and PromoterFinder DNA walking were sequenced and found to be not 
GSK-3a. YAC clone 33A9D was shown to have 5’ untranslated region of GSK-3a. 
Six YAC clone genomic libraries were constructed and 2Kb GSK-3a fragment 
upstream of cDNA was isolated. The fragment contains a TATA box located at 
position -230 to -227, and the transcriptional initiation site was at -129. 
To assess the transcriptional activity of this fragment, six genomic constructs of 
different lengths expanding from -1878 to +114 were transfected into neuroblastoma 
cell line SHSY5Y. The fragment from -831 to +114 of the sense strand (lK+) gave 
the highest promoter activity, about 650 folds higher than the basal control; whereas 
the anti-sense strand (lK-) showed about 340 folds higher than the control. 
ii 
Fragment from -1878 to +114 gave the lowest promoter activity, only 50 and 17 fold 
in the sense (2K+) and anti-sense strand (2K-), respectively, higher than the control 
At least ten introns had been found in the GSK-3a genome, but no intron exits of the 
both 3’ or 5’ end of the untranslated region. 
Since previous studies show the protein level and activity of GSK-3a increase after 
heat shock (46°C), both GSK-3a and -3p protein levels in SHSY5Y and A431 cell 
lines were assayed upon heat shock, sorbital and lithium choride stresses, but no 
change was detected. 
In short, a 2Kb GSK-3a promoter fragment is isolated from YAC clone 33A9D and 
the transcriptional starting site is at -129. Ten intons are found so far in the GSK-3a 

















此外，利用六種不同長度的G S K - 3 a啓動子片段去探索它在神經瘤細胞株 
8^¥5丫的考達。結果發現1尺5的有義鏈（ lK+)擁有最高的轉錄能力，大概高 
於對照組650倍，它的反義鏈（1反-)也有高於對照組340倍的表達能力。但是 
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Chapter 1 Introduction 
Glycogen synthase kinase-3 (GSK-3) is a multi-substrates serine/threonine kinase 
that was originally implicated in the regulation of metabolic enzymes such as 
glycogen synthase (Cohen, 1985; Roach, 1986) and ATP-citrate lyase (Hughes, et 
al., 1992). Other studies identified GSK-3 as protein kinase factor A (F^), the 
activator of the MgATP-dependent form of protein phosphatase-1 (Vandenheede, et 
aL, 1980; Hemmings, et al., 1981). Later observations showed that GSK-3a was 
involved in protein synthesis (Welsh and Proud, 1993), modulation of the 
transcription factor AP-1 and CREB (cAMP response element binding protein) 
(Boyle, et al., 1991; Plyte, et aL, 1992; Fiol, et al., 1994)，cell fate determination in 
Drosphila (Siegfried, et aL, 1992), dorsoventral axis formation in Xenopus (He, et 
aL, 1995; Pierce, et al., 1995), and chromosome segregation in Saccharomyces 
cerevisiae (Puziss, et aL, 1994). These studies suggested GSK-3 is involved in 
multiple cellular processes including metabolism, proliferation and development. 
•• 
1.1 Glycogen Synthase (EC 2.4.1.11) 
Glycogen synthase, which catalyzes the elongation of glycogen chains, is composed 
of four sub-units, each of molecular weight of 85 KDa. Its activity in cells is under 
both metabolic and endocrine control. In the late 1970s, it has been established that 
1 
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glycogen synthase is regulated by a phosphorylation/dephosphorylation mechanism. 
In this system, insulin activates the rate-limiting enzyme of glycogen synthesis, 
glycogen synthase, by reducing its phosphate content (Rosell-Perez, et al., 1964; 
Craig, et al., 1964; Skurat, et al., 1996). The following diagram shows a simple 
mechanism for phosphorylation and dephosphorylation of glycogen synthase: 
Kinases 
r “ ^ 
Glycogen synthase Glycogen synthase-P 
(active) ^' '^^^^^^^ ^ ^ ^ ^ ^ ^ (inactive) 
Protein phosphatase-1 
Glycogen synthesis 
Protein kinases catalyzing the phosphorylation reaction of glycogcn synthase havc 
been identified. Glycogen synthase is phosphorylated by eight protein kinases 
acting on at least nine sites (Table 1.1; Figure 1.1). One result is the definition of 
some new protein kinases, notably glycogen synthase kinase-3 (GSK-3) (Cohen, et 
a l , 1982). 'GSK-3 phosphorylates sites 3a and 3b and potently inactivates glycogen 
synthase. The phosphorylated glycogen synthase is an inactive form, resulting in 
dramatic reduction of glycogen synthesis (Cohen, 1985; Poulter, et al., 1988; Wang, 
etal., 1993). 
2 
Table 1.1 Kinases that phosphorylate glycogen synthase. 
Class of protein kinase Kinase for Glycogen synthase Regulator Sites 
phosphorylated 
CycTic nucleotide cAMP-dependent protein cAMP l a > 2 > lb 
dependent kinase 
cGMP-dependent protein cGMP 1 a > 2 > lb 
kinase 
Calcium ion dependent Phosphorylase kinase Ca?+ 2 
Calmodulin-dependent Ca^ + 2 > lb 
multiprotein kinase 
Nonspecific Glycogen synthase kinase-3 ？ 3a, 3b，3c 
Glycogen synthase kinase-4 ？ 2 
Glycogen synthase kinase-5 ？ 5 
Casein kinase-1 ？ not yet identified, 
but at least 6 
PKA: Cyclic-AMP-dependent protein kinase 
PhK: Phosphorylase kinase 
CaMPK: Calmodulin-dependent multiprotein kinase 
ISPK: Insulin-stimulated protein kinase 
GSK-4: Glycogen synthase kinase-4 
CK1: Casein kinase 1 
GSK-3: Glycogen synthase kinase-3 






C K 1 GSK-3 CK2 PKA CaMPK 
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Figure 1.1 The nine phosphoserine residues on rabbit skeletal muscle glycogen synthase. Serine 
residues phosophorylated in vitro are denoted (Nakielny, et al., 1991). The protein 
sequence surrounding the CK2 and GSK-3 sites is also shown (Wang, et al., 1993). 
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1.2 Glycogen Synthase Kinase-3 
In 1980, Cohen and co-workers purified a protein kinase highly specific for glycogen 
synthase from rabbit skeletal muscle. This kinase is distinctive from both cyclic-
AMP-dependent protein kinase and phosphorylase kinase in skeletal muscle. It 
appears to be more specific for glycogen synthase than other proteins. 
Phosphorylation by this glycogen synthase kinase causes a greater decrease in the 
activity of glycogen synthase than is produced by phosphorylation to the same extent 
with cyclic-AMP-dependent protein kinase or phosphorylase kinase. This enzyme 
was therefore named glycogen synthase kinase-3 (Embi, et al., 1980; Rylatt, et aL, 
1980). Phosphorylation produced by the above three glycogen synthase kinases are 
additive, implying that each protein kinase phosphorylates a distinct site or sites on 
glycogen synthase (Table 1.2). 
Table 1.2. Amino acid sequences on glycogen synthase phosphorylated by cyclic-
AMP-dependent protein kinase, phosphorylase kinase and glycogen 
synthase kinase-3 
Protein kinase Site Sequence R^f^ence 
Cyclic-AMP- 1 a ArgZ.ys-Arg-Ala-"Scr(P) —— .......— \ u ^ ^ ' e i ^ 7 \ ^ i . . -
dependent protein 
kinase 
• l b Gly-Ser-Lys-Arg-Ser-Asn-Ser(P)-Val-Asp-Thr-Ser-Scr- Huang, et al., 1977: 
Leu-Ser-Pro-Pro Proud, ei«/., 1977 
Phosphorylase 2 Pro-Lcu-Scr-Aig-Thr-Lcu-Scr(P)-Val-Scr-Scr-Lcu-Pro- l<ylaii. et al., 1979’ 
kinase Gly -Leu-Glu-Asp 1980； Embi, ei “/.’ 
1979; 
Glycogen synthase 3a，3b’ 3c Arg-Try-Pro-Arg-Pro-Ala-Ser(P)-Val-Pro-Pro-Scr(P)- Rylatt, et al., i980 
kinase-3 Pro-Ser-Leu-Ser(P)-Arg 
4 
At a similar time, Meiievede and colleagues were studying a protein termed Factor 
A (pA), it was capable of activating a dormant protein phosphatase (a complex 
between protein phosphatase-1 and inhibitor-2) in the presence of MgATP 
(Vandenheede, et al., 1980). In addition to activating the protein phosphatase, this 
protein exhibited glycogen synthase kinase activity and it was soon established that 
pA was equivalent to GSK-3 (Hemmings, et aL, 1982; Vandenheede, et al., 1989). 
This protein kinase thus exhibits counter-acting properties: the ability both to 
phosphorylate proteins, and, via the activation of a phosphatase, to stimulate protein 
dephosphorylation. 
1.3 Structure of Glycogen Synthase Kinase-3 
Two cDNA clones for GSK-3, GSK-3a and GSK-3p, were first isolated from rat 
brain by J. Woodgett in 1990. They are products of distinct genes (Plyte, et aL, 
1992). GSK-3a is located at chromosome 19ql3.1, where GSK-3p is at 
chromosome 3ql3.3 (Shaw, et aL, in press). The a-isoform encodes a 51 KDa 
polypeptide, while p-isoform encodes a 47 KDa protein with 85% amino acid 
identity to GSK-3a (Woodgett, 1990). The catalytic domains of the proteins show 
93% identity. However, the sequences outside of the kinase domain are quite 
distinct, and a Glycine-Serine rich segment is only found in the N-lerminal region of 



































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Glycogen synthase kinase-3 is predominantly in cytoplasm, and some significant 
amount is associated with membrane and nucleus. GSK-3a and -3p appear to be 
expressed in most tissues (Woodgett, 1990), but to different extent. GSK-3a and -
3p mRNA show the highest expression in human testis but low in lung, liver and 
kidney. The RNA level of GSK-3 in fetal tissue is higher than the corresponding 
adult tissues (Lau, et al., In press). In addition, the a-isoform is more dominant in 
most tissues than p-isoform. GSK-3a protein is highly expressed in lung, ovary, 
kidney and testis; whereas GSK-3p is highly expressed in brain and heart. Different 
expression of the two isoforms in different tissues suggest thal they are tissue 
specific, and may reflect distinct functions in cells. 
Glycogen synthase kinase-3 has highly conserved homologs in many organisms, 
including invertebrates and vertebrates. In yeast, the homologous enzymes are 
called MCK-I and MDS-1. MCK-I has 45% sequence identity with GSK-3 of rat 
within the catalytic domain, and MDS-1 has 57% sequence identity over 296 amino 
acids overlap with GSK-3a from rat (Puziss, et aL 1994). GSKA, a Dictyostelium 
homolog of GSK-3, shares 71% amino acid identity with the catalytic domain of the 
— 
human GSK-3p (Harwood, et al., 1995). Zeste-white 3幻'('聊(Zw3'^^) has been 
r 
shown to be the Drosophila melanogaster homologue of GSK-3p, with 88% 
homology within the catalytic domains and similar specificity for the known GSK-3 
protein substrates (Siegfried, et al., 1990; Bourouis, et al., 1990). In addition, a 
Xenopus homolog of GSK-3p, XGSK-3p which is 77% identical to Zw3'^^ and 94% 
to rat GSK-3p has been found, reflecting the high degree of conservation of GSK-3p 
in evolution (Dominguez, et aL, 1995). The identification of GSK-3 homologue in 
7 
these organisms offers good prospects for a detailed analysis of the pathways leading 
to and from GSK-3. 
1-4 Functions of Glycogen Synthase Kinase-3 
As mentioned above, GSK-3 was first identified as a protein kinase involving in the 
regulation of glycogen synthase via phosphorylation of a number of sites. There are 
at least nine sites of phosphorylation on glycogen synthase, four of which are 
targeted by GSK-3. Phosphorylation of these sites causes inactivation of glycogen 
synthase. Recently, numerous other substrates for GSK-3 have been found and 
biological experiments have implicated the enzyme having a role in lranscriplional 
regulation and development. 
1.4.1 Substrate Recognition 
Substrate recognition by GSK-3 has been studied in several cases. Some requires 
pHor phosphorylation and the other appears not to so. The substrates that require 
pi ior phosphorylation include glycogen synthase (DePaoli-Roach et al. 1983)，ATP-
citrate lyase (Ramakrishna et aL, 1990) and the transcriptional factor CREB (Fiol et 
«/.’ 1994). They are recognized by GSK-3 at the sequence motif -S-X-X-X-S(P)-
where the phosphate is introduced by a separate protein kinase (Roach, 1991). 
8 
Substrates not require prior phosphorylation include c-Jun and c-Myc transcriptional 
factors (Boyle etaL, 1991;Saksela et aL, 1992). 
The CREB transcriptional factor is phosphorylated by both GSK-3a and GSK-3p in 
a reaction that requires prior phosphorylation by cyclic AMP-dependent protein 
kinase (PKA) (Wang, et al., 1994). PKA phosphorylates CREB^^^ or CREB^^' at a 
single serine residue, Serine' '^  or Serine'-^\ respectively. Phosphorylation at this site 
creates the sequence motif S-X-X-X-S(P)-, a consensus site of the GSK-3 (Fiol, et 
al., 1987). Upon stimulation of the adenyl cyclase pathway, CREB is 
phosphorylated on serine''^^ by PKA, which leads to a dramatic increase in its trans-
regulatory function (Gonzalez et al. 1989; Lee et al., 1990). Recently, Ferguson plot 
analyses demonstrate that phosphorylation of CREB by PKA and GSK-3 result in an 
increase in the spherical size and the net positive surface charge of the CREB/DNA 
complex, and reveal that CREB associates as a tetramer both in the presence and 
absence of DNA. These findings imply that in addition to the regulation of 
transactivation, a second consequence of the phosphorylation of CREB alters the 
secondary structure and net charge of CREB/DNA complex resulting in an alteration 
in binding affinity (Bullock, et al., 1998). 
On the other hand, substrate such as c-Jun, one of the components of AP-1, which 
does not require prior phosphorylation has been shown to be phosphorylated in a 
region proximal to the DNA-binding domain by GSK-3 in vitro and in vivo. These 
phosphorylation events inhibit binding of c-Jun to its target promoter, the TRA-
response element (TRE), leading to a reduction in DNA binding activity 
9 
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(Nikolakaki, et al., 1993). In addition, c-Jun-related proleins JunD and JunB are 
subject to similar regulation by GSK-3 in intact cells (de Groot, et al., 1992). 
The largest (e) subunit of translation initiation factor eIF2B is also a substrale for 
GSK-3. GSK-3 phosphorylates eff2B at its 8-subunit at Serine*^ *()，results in the 
inactivation of eEF2B (Welsh, et al., 1998). Since the guanine nucleotide-exchange 
factor eU^2B mediates exchange of GDP bound to eU 2^ for GTP after each round of 
translation initiation, changing its activity may play an important role in controlling 
peptide-chain initiation (Welsh, etal., 1996). 
1.4.2 Glycogen Synthase Kinase-3 Homologs 
1.4.2.1 Drosophila 
Drosophila shaggy {zeste-white 3) protein kinases, a serine/threonine protein kinase 
homologue of mammalian GSK-3, has a similar effect on the phosphorylation of c-
— 
Jun, results in reduction of binding of the protein to its cognate DNA sequence. In 
transgenic flies, GSK-3p can substitute for zeste-white ？狀(Ruel, et al. 1993), so 
that a possible function of Zw3‘�^' in the fly is to regulate the transcription factors. 
Furthermore, Z w f ^ is also a neurogenic gene to determine equivalent groups of 
neural precursor cells, under the control of the Notch and Delta transmembrane 
proteins. So Zw3'^'^' is also required for the lateral signal (Ruel, et al., 1993). In 
addition, epistatic relationship study between Zw3'^ ^ and gain and loss of function 
10 
alleles of Notch indicate that Zw3^/GSK-3 is part of a signalling pathway 
downstream of Notch (Ruel, et al., 1993). The end-point of this signal would lead to 
a repression of achaete and scute, the genes conferring neural potential (Ghysen, et 
aL, 1988). 
Other studies found that Zw3^' is an essential component of the Wingless (Wg) 
signalling pathway. Wg is a key molecule that indicates cell fale and positional 
information of the epidermal cells in each embryonic segment and hence regulates 
development processes in Drosophila, Xenopus and mouse. In early role of Wg is to 
stabilize engrailed (en) expression by initiating a phase of en autoregulation in the 
adjacent more posterior cells. Analysis of the regulation of en expression in Zw3^ 
mutant embryo found that Zw3'^^ functions as a repressor of en autoactivation, since 
en protein is not maintained correctly and causing 11 stripes in Zw3'^^ mutant (about 
twice broader than the wild-type). It is suggested that Wg signalling is mediated 
through Zw3'''^^. Wg signalling functions to dismantle Zw3''^^ repression of en 
autoregulation and stablizes en expression. As a result, the cell fates are correctly 
established within each embryonic segment (Siegfried, et al., 1992; 1994). 
1.4.2.2 Xenopus 
The Xenopus GSK-3 homolog, XGSK-3p which is more closely related to GSK-3p 
than GSK-3a, is expressed in Xenopus eggs and early embyos. Microinjection of 
inactive mutant K85R of GSK-3p mRNA into a ventrovegetal blastomere of eight-
11 
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cell embryos caused ectopic formation of a secondary body axis which contains a 
complete set of dorsal and anterior structures. The mutation was substantially 
reduced by coinjecting with XGSK-3p mRNA. In addition, in isolated ectodermal 
explants, the mutant activated the expression of neural tissue markers, including 
NCAM, XJF3 and OtX2, as well as anterior ectodermal and cement gland markers 
XA1 and XAG1 (Dominguez, et al., 1995; He, et aL, 1995; Pierce, et al., 1995; 
1996). It is suggested that XGSK-3p regulates the determination of dorsal-ventral 
axis of neural tissue by functioning as an inhibitor of dorsal structures. 
1.4.2.3 Dictyostelium and Others 
Studying the role of GSKA in Dictyostelium found that GSKA is not essential for 
cell growth, chemotaxis, or cell differentiation, but it is required to determine the 
choice between prespore and prestalk B (pstB) cell fate. Normal expression of thc 
prestalk A (pstA) and higher level with earlier expression of pstB were found in 
gskA' mutants, resulting in the grossly expansion of the prespore cells. A similar 
phenomenon has also been found in the absence of cAMP. This observation 
suggests that cAMP induces prespore cells and represses pstB would be expected to 
be mediated through GSKA (Insall, 1995). 
Besides, MDS1 and MCK1 found in yeast, encode protein kinases with substrate 
specificities characteristic of mammalian GSK-3. MDS1 and MCK1 perform 
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redundant functions within the chromosome cycle and play a role in the process of 
chromosome segregation (Puziss, et al., 1994). 
1.4.3 Regulation of Glycogen Synthase Kinase-3 in 
Mammalian Systems 
GSK-3 is inactivated by insulin, lt was originally thought lo occur via the MAP 
kinase/p90rsk cascade because wortmannin inhibited both the activation of MAP 
kinase and p90''^ as well as of GSK-3 (Welsh and Proud, 1993; Cross et al., 1994; 
Welsh et al., 1994). However, recent data show that insulin signalling to GSK-3 in 
lOTl/2 fibroblasts may occur via a PI 3-kinase-regulated step which involves PKB 
(Cross, et aL, 1994; Welsh et al., 1994). In contrast, the activation of p90''^ and 
inactivation of GSK-3 by EGF can be partially blocked by the use of dominant-
negative MEK, showing that this pathway does play a role in signal transduction to 
GSK-3 by EGF (Figure 1.3) (Elder-Finkelman, et al., 1995). 
Recent study has shown that the activity of GSK-3 is inactivated by Wg in mouse 
lOTl/2 fibroblasts. The signalling is shown to be distinct from both insulin- and 
EGF-mediated inactivation of GSK-3, suggesting that WgAVnt utilizes a novel 
signal transduction pathway to GSK-3. Using a specific inhibitor R031-8220, which 
is an effective inhibitor against both phorbol ester-sensitive and -insensitive PKC 
isoform, to treat mouse lOTl/2 fibroblasts showed that it can abolish the inhibition 
13 
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of GSK-3 aclivity by Wg. lt is sugesled that lhc PKCs lics upslrcam of GSK-3 in 
Wg signal transduction (Cook, etcil., 1996) (Figure 1.3). 
Wg is the homolog of the proto-oncogene Wnt-1. Wnt-1 is found to be expressed in 
mouse brain, ring around midbrain-hindbrain junction (Nusse, et al., 1992). In the 
absence of a Wnt-1 signal, expression of En-1 from the Wnt-1 is sufficient to 
substantially rescue early midbrain and anterior hindbrain development. These 
results suggest that a major role of Wnt-1 signalling in the mammalian brain is to 
maintain En expression. This is identical to a role proposed for Wg signalling in the 
Drosophila epidermis, demonstrating that this aspect of the regulatory pathway has 
been conserved from flies to mice (Danielian, et al., 1996) 
EGF . Insulin WgAVnt 
MEK ^ ' PI 3-kinase 
MTAP kinase ？ . . .-PKC 
- P K B v " " Z 
‘ p90"k Z 
� ^ “ ^ ^ ^ - ^ ^ GSK-3 Y 
Figure 1.3 Models of possible signal transduction routes to GSK-3 utiliiccd by E G F and 
insulin. 
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GSK-3 has been implicated in the control of several metabolic enzymes and 
transcriptional factors in response to extracellular signals. In the past, the enzyme 
has been considered to be a serine/threonine protein kinase, but it was recently 
reported to contain Tyrosine(P). Hughes et aL, (1993) reported that only one tyrosine 
residue in recombinant GSK-3 is phosphorylated in insect cells (Tyr216 in GSK-3p 
and Tyr279 in GSK-3a). 
In the study of the signal transduction mechanism of GSK-3a in A431 cells, GSK-
3a was found to exist in a highly tyrosine-phosphorylated/activated state in resting 
cells, but could be tyrosine-dephosphorylated and inactivated down to less than 15% 
by okadaic acid (a specific inhibitor of protein phosphatase types 1 and 2A). The 
results provided initial evidence that serine/threonine dephosphorylation may 
possibly be involved in the tyrosine phosphorylation and concurrent activation of 
GSK-3a. Further study by Yang's group in 1997 showed that GSK-3a can be 
regulated by reversible tyrosine phosphorylation/dephosphorylation in A431 cells. 
In this experiment, protein tyrosine kinase (PTK) inhibitor such as tyrphostins and 
genistein induced tyrosine dephosphorylation and concurrent inactivation of GSK-
3a in A431 cells. When removing these inhibitors, the activity and phosphotyrosine 
r 
content of GSK-3a was reversed to the original level. In addition, the activity of 
PTK inhibitor can be prevented by pretreating the cells with protein tyrosine 
phosphatase (PTP) inhibitor such as orthovanadate. 
On the other hand, GSK-3p has been shown to be specifically inhibited by 
phosphorylation which catalyzed by certain isoforms of PKC (Boyle, et al., 1991). 
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This phosphorylation inactivales GSK-3p providing a potential mcchanisni l'or 
negative control by agonists of phosphatidylinsitol turnover. The tyrosine 
phosphorylation site has been identified as residue 216 of GSK-3p. This residue is 
in an analogous position to the tyrosine-phosphoryIated in MAP kinase by MEK and 
is conserved in all GSK-like protein (Figure 1.4). When complete prevention of 
tyrosine phosphorylation by mutation of Tyrosine^'^ to Phenylalanine in GSK-3p 
results in a further 10-fold decrease in activity when expressed in insect cells. The 
result indicates that tyrosine phosphorylation is necessary for biological function of 
GSK-3p. 
VRGEPNVSYICSRYYRAPE human GSK-3a 
VRGEPNVSYICSRYYRAPE human GSK-3p 
VRGEPNVSYICSRYYRAPE rat GSK-3p 
LHGEPNVSYICSRYYRAPE zw3Maggy 
IKGETNVSYICSRHYRAPE D. discoideum GSK-3 
DHTGFLTEYVATRWYRAPE p^ ^ MAP kinase 
Figure 1.4 Conservation of the phosphortyrosine-containing region in GSK-3 homologucs and 
comparison wilh lhc rcgulalory lyrosinc ol" pp^^ M A P kinase. Thc bold Y indicated lhc 
phosphorylalcd lyrosinc. 
1.4.4 r The role of Glycogen Synthase Kinase-3 in 
Mammalian Brain 
GSK-3 has been found present in brain neurons, and several neuronal substrates such 
as tau protein, neurofilament, etc., are phosphorylated by GSK-3. The expression of 
two isoforms has been shown to be different in the rat brain at postnatal age. GSK-
16 
3p is high at gestation dayl8, and decreases sharply to a constant levd after 5 weeks. 
In contrast, GSK-3a is found in a nearly constant level throughout the different 
stages, but with a elevated expression during the first 3 weeks after birth (Figure 1.5) 
(Hanger, etaL, 1992; Takahashi, etal,, 1994). 
A number of studies have implicated GSK-3 a good candidate for generating 
hyperphosphorylation of tau in Alzheimer's disease (Lovestone, et al., 1994). GSK-
3a and -3p can phosphorylate recombinant tau produced in E.coli, generating a 
number of PHF-tau epitopes (Hanger, et al., 1992; Mandelkow, et al., 1992), this 
phosphorylation reduces the electrophoretic mobility of tau, a characteristic of PHF-
tau (Figure 1.6). However, these studies have also shown that GSK-3p, but not 
GSK-3a, is more potent in phosphorylating tau protein. 
1.4.4.1 Glycogen Synthase Kinase-3p 
As mentioned above, tau protein is phosphorylated by GSK-3. Later studies show 
that GSK-3p is equivalent to tau protein kinase I (TPK1) which modifies normal tau 
in vitro to a highly phosphorylated form observed in Alzheimer's disease brain 
(Ishiguro, et al., 1993). Alzheimer 's disease is characterized by neuronal cell death, 
and deposits of neurofibrillary tangles and senile plaques. 
17 
Developmental changes in the levels ofGSK-3a and -3p in rat brain 
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Figure 1.5 DcvcU)pmcnlal changes in lhc levels of GSK-3a and -3p in lhc rat brain. Thc black square is 










































































































































































































































































































































































































































































































The pair helical filament (PHF) is a main component of neurofibrillary tangles, 
which consists of hyperphosphorylated tau (PHF-tau). Hyperphosphorylation 
reduces the affinity of normal tau for microtubules and leads to microtubules 
destabilzation. So that, hyperphosphorylation of tau is believed to be the critical 
event that leads to filament disassembly. Although some studies have shown that 
mitogen-activated protein kinase, glycogen synthase kinase-3 (GSK-3) and neuronal 
cdc2-like kinase phosphorylate tau protein activities at a number of sites that are 
phosphorylated in PHFs, only elevation of GSK-3a or GSK-3p activity in COS cells 
induces phosphorylation of transfected tau (Lovestone, et al., 1994; Anderton, et al., 
1995). The aberrant regulation of GSK-3a or -3p may be a pathogenic mechanism 
in Alzheimer's disease. 
Addition to the formation of PHF, senile plaques contain extracellular deposits of p-
amyloid protein (Ap), which induces neurotoxicity by activation of GSK-3p in rat 
hippocampal culture (Takashima, et al., 1993; 1995), resulting in accumulation of 
amyloid precursor protein (APP) derivatives in the cytoplasm of neurons. The 
exposure of neurons to Ap induces in GSK-3p activity, and thus may lead to the 
high degree of phosphorylation of tau, followed by instability of microtubules and 
r 
disruption of axonal transport (Takashime, et al., 1996). In addition, nontoxic 
amyloid beta peptide (Ap) 1-42 suppresses acetylcholine synthesis in cholinergic 
neurons at very low concentrations (10-100nM). The major cause of the reduction 
may be due to an inadequate supply of acetyl-CoA owing to inactivating of pyruvate 
dehydrogenase (PDH) by GSK-3p in mitochondria (Imahori, et al., 1997). 
Therefore, a specific increase in soluble Ap (1-42) in Alzheimer disease brain may 
20 
act as an activator of GSK-3p which in turn inactivates PDH by phosphorylation. 
The poor energy metabolism, accumulation of lactate and shortage of acetylcholine, 
are well known symptoms of Alzheimer disease. Therefore, GSK-3p may be the key 
to the pathogenesis of Alzheimer disease. 
As mentioned earlier, insulin regulates GSK-3 through 
phosphorylation/dephosphorylation mechanism. A recent report has shown that tau 
phosphorylation and function can be regulated through a signal transduction pathway 
by insulin or IGF-1. Insulin and IGF-1 induce inhibition of GSK-3, resulting in tau 
dephosphorylation and increased microtubule binding to normal tau in human 
neuronal NT2N cells. These effects are mediated through the inhibition of GSK-3 
via the phosphatidylinositol 3-kinase/protein kinase B signalling pathway (Hong, et 
al., 1997a). Furthermore, a widely used drug, lithium, for treating bipolar (manic-
depressive) disorder, also reduces the phosphorylation of tau, enhances the binding 
of tau to microtubules, and promotes microtubule assembly through direct and 
reversible inhibition of GSK-3 in human NT2N neurons (Hong etal., 1997b). These 
results all point to the importance of GSK-3 in the function of neuronal system. 
r 
1.4.4.2 Glycogen Synthase Kinase-3a 
GSK-3 is one of protein kinases that phosphorylates and inactivates glycogen 
synthase. Insulin stimulates glycogen synthesis in muscle by causing the 
dephosphorylation and activation of glycogen synthase (Parker, et aL, 1983). In the 
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study of diabetic rat, it was found that the mRNA level of GSK-3a was increased to 
143% of normal, but the level could be normalized by insulin supplementation. This 
study shows that the chronic effect of insulin may decrease the level of GSK-3a 
mRNA by altering its stability (Rao, etal., 1995). 
In addition to the role of regulation of glycogen synthase, recent studies have shown 
that GSK-3a phosphorylates neurofilament, suggesting that GSK-3a may play a 
potential role in the regulation of diverse brain function and important role in 
tumorigenesis. 
There are at least four major sites in neurofilament of medium chain (NF-M): Ser^ ® -^
Pro, Ser506_Pro, Ser^^^-Pro and Ser^^^-Pro phosphorylated by GSK-3a in vivo (Yang, 
et al., 1995a). Recent study has also shown that GSK-3a can phosphorylate 
neurofilament heavy-chain (NF-H) side arm at the consecutive Lys-Ser-Pro- (KSP) 
repeat. There are five KSP repeats in NF-H. However, the precise position of 
phosphorylation is not known (Bajaj, etal,, 1997). 
An MgATP-dependent multisubstrate protein phosphatase can be activated in the 
r 
presence of MgATP and protein kinase F� (GSK-3a) . In the study of Schizophrenic 
patient lymphocytes, there is a clearly reduction of both protein level and activity of 
GSK-3a and a reduction of protein phosphatase activity (Table 1.3) (Yang, et aL, 
1995b). 
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Table 1.3 Statistical Dysfunction of kinase FA/GSK-3a in lymphocytes of 
Schizophrenic patients. 
Lymphocytes Cell number Cell protein (mg) GSK-3a activity 
(units/mg) 
Normal ^2X10^ 0.65±0.08 14.8土2.4 
(N=37) 
Schizophrenia -2X10^ 0.63±0.07 2.8±1.6* 
(N=48) 
* p<0.01 vs. normal control by Student's t-test 
1.4.5 Glycogen Synthase Kinase-3a in Certain Tumor Cells 
In the studies of cell dedifferentiation, a significant amount of GSK-3a protein level 
and its activity are increased at different stages of tumor formation. There are about 
1,300% increase of GSK-3a content in human hepatoma dedifferentiation when 
compared to the normal (Figure 1.7). This observation has also been found in the 
human thyroid tumor cell dedifferentiation and cervical carcinoma. Therefore, 
GSK-3a may possibly be used as a marker protein for clinical diagnosis of the status 
of human hepatoma, thyroid tumor cell dedifferentiation and cervical carcinoma 
during prediagnosis and postdiagnosis of the disease (Lee, et aL, 1995; Yang, et al., 
1995c; Yang, etal., 1996b). 
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The densitometric quantification ofGSK-3a 
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Figure 1.7 The densitometric quantification of GSK-3a on the immunoblotting analysis in well and 
poorly differentiated human liver carcinoma tissues relative to normal liver tissues. 
(N=normal liver tissues, Cl=well differentiated liver carcinoma tissues, C2=poorly 
differentiated liver carcinoma tissues) (Yang, et al., 1996b). 
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1.5 Objectives 
Many studies have shown that glycogen synthase kinase-3 or its homologs play a 
diversified role. A lot of information on the regulation of GSK-3 is at post-
tranlational level. To understand the transcriptional regulation of GSK-3, it is 
necessary to isolate the 5，untranslated promoter region of GSK-3. Therefore, the 
first aim of my study is to isolate the GSK-3a promoter region. In the course of this 
study, the genomic structure of GSK-3a is also resolved. Recent study has shown 
that stress-activated protein kinases (SAPKs) are able to phosphorylate tau protein 
(Reynolds, et al., 1997), and different stimulation such as Antinomycin D, heat and 
sorbital can activate SAPKs in different cell lines to different extents (Zanke, et aL, 
1996). Therefore, the second aim of my study is to examine the protein level of 








Chapter 2 Materials and Methods 
2.1 General Techniques 
2.1.1 Plasmid Minipreparation 
2.1.1.1 Alkaline lysis method was modified from Maniatis et aL, (1989). A 
single bacterial colony was inoculated into 5ml of LB medium containing 50 ^g 
ampicillin/ml. The culture was incubated overnight at 3 7 ¾ with vigorous shaking. 
Bacterial pellet of about 1.5ml culture was collected by centrifugation at 14,000 xg 
for 30 seconds. The pellet was resuspended in 300|il of P1 (50mM Tris-HCl; pH 
7.5, lOmM EDTA, 100 ^g/ml RNase A). After 300^il ofP2 (0.2M NaOH, 1% SDS) 
was added, the mixture was inverted 4-6 times without shaking. Then 300^il of P3 
(2.55M potassium acetate; pH 4.8) was added followed by inverting 4-6 times. 
Supernatant containing plasmid was collected by centrifugation at 14,000 xg for 15 
minutes, and transferred to a new microcentrifuge tube. 0.7 volume of isopropanol 
was added into the supernatant. Plasmid pellet was obtained by centrifugation at 
14,000 xg for 15 minutes. Then the pellet was washed with 70% ethanol and dried 
in oven. Finally, the pellet was resuspended in 30 i^l of deionized water. 
2.1.1.2 The Quantum Prep plasmid miniprep kit from Bio-rad (732-6100) is 
an optimized alkaline lysis method for purifying plasmid DNA from bacterial 
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cultures. A single colony was inoculated into 5ml of LB containing 50 ^g 
ampiciIIin/ml, and incubated at 3 7 ¾ overnight with vigorous shaking. 1.5ml 
overnight culture was transferred to a microcentrifuge tube and was spun down by 
centrifugation at 14,000 xg for 30 seconds. The pellet was resuspended in 200^1 of 
Cell Resuspension Solution, and mixed with 250^1 of Cell Lysis Solution by 
inverting 10 times. Then, 250^1 of Neutralization Solution was added, and the tube 
was inverted 10 times until a visible precipitate was formed. The cell debris was 
removed by centrifugation at 14,000 xg for 5 minutes. The supernatant containing 
plasmid was mixed with 200^il of matrix suspension and transferred to a Spin Filter, 
then pelleted by centrifugation at 14,000 xg for 30 seconds. The matrix was washed 
with 500^il of Wash Solution by centrifugation at 14,000 xg for 30 seconds. 
Afterwards, the matrix was washed with 500^il of Wash Solution again by 
centrifugation at 14,000 xg for 2 minutes. Finally, the plasmid was eluted by lOO i^l 
of deionized water by centrifugation at 14,000 xg for 30 seconds. The eluted DNA 
was quantified by agarose gel or by OD260. 
2.1.1.3 Wizard® Plus SV Minipreps DNA Purification System was from 
Promega (A146Q). Single colony was inoculated into 5ml of LB containing 50 i^g 
ampicillin/ml, and incubated at 3 7 ¾ overnight with vigorous shaking. 1.5ml of 
bacterial pellet was obtained by centrifugation at 10,000 xg for 5 minutes. The pellet 
was resuspended in 250|il of Cell Resuspension Solution (50mM Tris-HCl; pH 7.5, 
lOmM EDTA, 100 ^g/ml RNase A), mixed with 250^il of Cell Lysis Solution 
(0.2M NaOH, 1% SDS) by inverting the tube 4 times. The mixture was incubated in 
room temperature for about 2 minutes until the cell lysate was cleared. Then, lO i^l 
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of Alkaline Protease Solution was added into the mixture and mixed by inverting the 
tube 4 times. 350^1 of Neutralization Solution (4.1M guanidine hydrochloride, 
0.76M potassium acetate, 2.1M glacial acetic acid; pH 4.2) was added into the cell 
lysate. The supernatant containing plasmid was collected by centrifugation at 14,000 
xg in a microcentrifuge for 10 minutes at room temperature, and transferred to the 
prepared Wizard® Plus SV Minipreps Spin Column. The supernatant was 
centrifuged at 14,000 xg for 1 minute to discard the flow-through. Then the column 
was washed with 750^il of Minipreps Column Wash Solution (60mM potassium 
acetate, lOmM Tris-HCl; pH 7.5, 60% ethanol) by centrifugation at 14,000 xg for 1 
minute. The column was washed again with 250|iI of Minipreps Column Wash 
Solution by centrifugation at 14,000 xg for 2 minutes. Finally, the plasmid was 
eluted by adding 100^1 of Nuclease-Free Water to the column by centrifugation at 
14,000 xgfor 1 minute. 
2.1.2 Large Scale of Plasmid DNA Purification using 
QL^,GEN-tip 500 Cartridge 
r 
This method was modified from the QLA.GEN Plasmid Purification Handbook 
01/97. A single colony was inoculated in 500ml of LB containing 50 ^g 
ampicillin/ml, and incubated at 3 7 ¾ for overnight with vigorous shaking. The 
overnight culture was harvested by centrifugation at 6,000 xg (JA14, 7,500 rpm; 
Model J2.21 Centrifuge, Beckman) for 15 minutes at 4 ¾ . The bacterial pellet was 
resuspended in 10ml Buffer P1 (50mM Tris-HCl; pH 8.0, lOmM EDTA, 100 ^g/ml 
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RNase A). The cell suspension was lysed by adding 10 ml Buffer P2 (200mM 
NaOH, 1% SDS) by gently inverting 4-6 times, and incubated at room temperature 
for 5 minutes. The cell lysate was then mixed with lOmI of chilled Buffer P3 (3.0M 
potassium acetate; pH 5.5) gently by inverting 4-6 times, and incubated on ice for 
15-20 minutes. The supernatant containing plasmid was saved by centrifugation at 
20,000 xg (JA20, 11,500 rpm)for 30 minutes at 4®C. The supernatant was 
transferred to a fresh tube and was re-centrifuged for 15 minutes (JA20, 11,500 rpm) 
at 4 ¾ to remove all remaining particles. 
A QIAGEN-tip 500 column was equilibrated by 10 ml of Buffer QBT (750mM 
NaCl, 50mM MOPS; pH 7.0, 15% isopropanol, 0.15% Triton® X-100). Half of the 
supernatant was applied into the equilibrated column and the plasmid was allowed to 
enter the resin by gravity flow. The column was then washed with 60ml of Buffer 
QC (l.OM NaCl, 50mM MOPS; pH 7.0’ 15% isopropanol). The plasmid DNA was 
eluted by 15ml of Buffer QF (1.25M NaCl, 50mM Tris-HCl; pH 8.5, 15% 
isopropanol). The above procedure was repeated two times to purify the plasmid 
DNA in the remaining supernatant. 
r 
The plasmid DNA was pooled together and precipitated by adding 0.7 volume of 
isopropanol. After incubated on ice for 15 minutes, the DNA was recovered by 
centrifugation at 14,000 xg for 30 minutes at 4°C. The pellet was resuspended in 
0.5ml of QF Buffer. Then the suspension was extracted by 
phenol/chloroform/isoamyl alcohol (25:24:1) extraction and followed by 
chloroform/isoamyl alcohol (24:1) extraction. The aqueous phase containing 
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plasmid DNA was precipitated by 0.7 volume of isopropanol, and collected by 
centrifugation at 14,000 xg for 10 minutes. The DNA pellet was washed with 70% 
ethanol at least two times and dried in the culture hood. Finally, the DNA pellet was 
resuspended in 200^1 of deionized water and kept at -20°C for further use. 
2.1.3 Extraction of Human blood genomic DNA 
30 ml of human blood was collected into EDTA tube, and the cells were spun down 
at 2,000 xg for 15 minutes at room temperature. Then, blood cells were washed 
with equal volume of 0.1% Nonidet and 0.9% NaCl solution twice by centrifugation 
at 2,000 xg for 15 minutes at washed cells were lysed in 10 ml lysis buffer (7 M 
urea, 0.3 M NaCl, 10 mM EDTA, 10 mM Tris-HCl; pH 7.5) and 2 ml of 10% SDS. 
The lysed cells were incubated at 3 7 ¾ for 10 minutes, and followed by 
phenol:chloroform (2:1) extraction. The aqueous phase was collected and mixed 
with 2 ml of 10% SDS, and incubated at 3 7 ¾ for 15 minutes. Then the mixture 
was further purified by phenol:chloroform extraction again. The aqueous phase 
containing DNA was precipitated by 2 volumes of absolute ethanol, and the DNA 
r 
was collected by centrifugation at 14,000 xg for 15 minutes at room temperature. 
The DNA pellet was dried in air and dissolved in 5 ml TE buffer. After incubating 
in 0.5% SDS and 100 ^g proteinase K/ml at 5 5 ¾ overnight, the DNA was extracted 
by phenol:chloroform again. The aqueous phase containing DNA was precipitated 
by 2 volume of absolute ethanol. And the dried DNA pellet was dissolved in 500 ^1 
TE buffer, and finally quantified by OD260 and OD280. 
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2.1.4 UV Spectroscopy for determining DNA/RNA 
Concentration 
For determination of DNA/RNA concentration, quartz cuvette was used to measure 
optical density at the wavelength of 260 nm. Suitable dilution of DNA/RNA sample 
was transferred to quartz spectrophotometer cuvette, and setting blank 
spectrophotometer with deionized water. The DNA/RNA sample was scanned from 
range of OD200-OD300 by Spectrophotometer (U-2000, Hitachi). An OD260 of 1 
corresponds to 50 ^g/ml for double-stranded DNA, 40 ^ig/ml for single-stranded 
DNA and RNA. Ratio of OD260 to OD280 was used to determine the purity of 
sample. The ratio greater than 1.8 indicated pure nucleic acids. 
2.1.5 Agarose Gel Electrophoresis of DNA 
The agarose gels were prepared with 0.8-1.5% (w/v) agarose (Ultrapure, Biorad) 
dissolved in IX TAE (40mM Tris-acetate, lmM EDTA) or IX TBE (90mM Tris-
borate, 2mM EDTA) buffer containing 0.5 昭 ethidium bromide (EtBr)/mI. The 
c 
volume of DNA samples was adjusted to 10-40ml with water. 6X agarose gel-
loading buffer (0.25% bromophenol blue, 40% (w/v) sucrose, 40mM EDTA) was 
added to the DNA sample to a final concentration of IX. After loading the samples 
into the wells, electrophoresis was performed at constant voltage of20-120V in a gel 
tank containing IX TAE or IX TBE. After electrophoresis, DNA was visualized on 
Spectroline Model TC-302 UV transilluminator (302nm) and photographed with 
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Polaroid 667 instant film through a HOYA(25A) red filter. Gel was ready for 
Southern blotting or fragment preparation. 
2.1.6 Purification of DNA Fragment from Agarose Gel 
using GeneClean III ®(BIO 101 Inc.) Kit 
The band containing the desired DNA was cut out from the TAE gel using a razor 
blade. 3 volumes of 6M NaI solution was added. After melting the gel at 5 0 ¾ for 5 
minutes，5^il Glassmilk® silica matrix was added. The mixture was kept at room 
temperature for 15 minutes with occasional shaking. The suspension was then 
centrifuged at 14,000 xg for 15 seconds. The pellet was washed with 0.7ml of NEW 
WASH solution for at least 3 times. The washed pellet was resuspended with 30-
50^d of deionized water, and the supernatant containing DNA was recovered by 
centrifugation at 14,000 xg for 1 minute. 
2.1.7 Restriction Digestion of DNA 
r 
Restriction digestion of DNA was carried out in a volume of 15-lOOjnl in the 
appropriate buffer as suggested by the supplier. The reaction mixture was incubated 
at 37°C for an hour, or overnight. After digestion, the mixture was analyzed by 
agarose gel electrophoresis, or/and Southern blotting. 
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2.1.8 Southern Blot 
The procedure was modified from the protocol of VacuGene™ XL Vacuum blotting 
System from Pharmacia. GeneScreen Plus® membrane was wetted in deionized 
water, and then soaked in 10X SSC for 5 minutes. The pre-treated membrane was 
placed on a porous screen, followed by a plastic mask on the membrane. After 
loading the gel, and letting it gradually slide onto the membrane, the VacuGene XL 
pump was switched on between 50-60 mbar. Depurination was started by pouring 
0.2M HC1 onto the gel for about 30 minutes until the bromophenol blue turned 
yellow. Then followed by denaturation of pouring denaturation buffer (0.5M NaOH, 
0.5M NaCl) onto the gel for about 30 minutes, the gel was neutralized by 
neutralization buffer (lM Tris-HCl, pH 7.5; 1.5M NaCl) for 30 minutes. 
Afterwards, the DNA on the gel was transferred to the membrane by sucking force in 
10X SSC buffer for about 90 minutes. After finishing the Vacuum Transfer, the 
membrane was marked and rinsed with 10X SCC for 10 minutes to remove the 
remaining agarose. The marked membrane was dried in air for 30 minutes, and the 
DNA was fixed by UV light (DNA Transfer Lamp, Fotodyne) for 4 minutes. 
r 
2.1.9 Probe Labelling 
2.1.9.1 Probe labelling by random priming using Oligolabelling Kit from 
Pharmacia Biotech. 100ng of GSK-3a cDNA was denatured at 95^C for 2 minutes, 
before mixing with lOp,l of Reagent Mix (Buffered aqueous solution containing 
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dATP, dGTP, dTTP, and random hexadeoxy-ribonucleotides) and 50^Ci [a-
32 
P]dCTP in a total volume of 49^1 reaction mixture. After adding 10 units of 
Klenow Fragment, the mixture was incubated at 37°C for an hour. The un-
incorporated [a-^^]-dCTP was removed by Sephadex G-50 spin column. The 
labelled GSK-3a cDNA was then used for hybridization or stored at -20°C for 
further use. 
2.1.9.2 Probe labelling by Nick Translation Kit (Amersham Life Science). 
100ng of DNA fragment was mixed into a total volume of 50^il mixture containing 
lO i^l of Nucleotide Buffer solution (lOO i^M each of dATP, dGTP, dTTP in Tris-
HCl; pH 7.8’ 2-mercaptoethanol and MgCl2), 50^Ci [a-^^P]-dCTP and 5^1 of 
enzyme solution (0.5 units DNA polymerase V i^l and 10 pg DNase/^1 in Tris-HCl; 
pH 7.5, MgCl2, glycerol and bovine serum albumin). The reaction mixture was 
incubated at 16¾ for 90 minutes. The un-incorporated [a-^^]-dCTP was removed 
by Sephadex G-50 spin column. The labelled DNA fragment was then used for 
hybridization or stored at -20°C for further use. 
c 
2.1.10 Hybridization by Radio-labelling 
The DNA membrane was pre-hybridized in 5ml of Rapid-hyb Buffer (RPN 1636， 
Amersham Life Science) at 6 5 ¾ for 30 minutes with even rolling. Then 5 i^l of 
denatured probe was added into the buffer, and further incubated at 65^C for about 2 
hours with even rolling. After hybridization, the membrane was washed with 2X 
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SSC twice at room temperature, followed by washing with 2X SSC, 0.2% (w/v) SDS 
twice at 6 5 ¾ for 5 minutes each. Then the membrane was washed with 2X SSC, 
0.1 % (w/v) SDS once at 65°C for another 5 minutes. Finally, the washed membrane 
was wrapped by cling film and exposed on film overnight. 
2.1 • 11 DNA Sequencing Reaction 
2.1.11.1 ^ Dideoxy-Sequencing Kit was purchased from Pharmaica 
Biotech. 1.5-2^g double-stranded template was denatured in 2M sodium hydroxide 
at room temperature for 10 minutes. Denatured DNA was precipitated by 3M 
sodium acetate (pH 4.8) and absolute ethanol, then placed at -20°C for 15 minutes. 
Precipitated DNA was collected by centrifugation at 14,000 xg for 15 minutes. The 
pellet was washed by 70% ethanol and dried briefly in a 60°C oven. Finally, the 
pellet was dissolved in lO i^l deionized water. Primer was annealed to the 
resuspended template in Annealing buffer (lM Tris-HCl; pH 7.6, 100mM MgCl2, 
160mM DTT), and the mixture was incubated at 60^C for 10 minutes. After cooling 
to room temperature, the mixture was ready for labelling reaction. The annealed 
template/primer mixture, [a-^^] dATP and 16 units of T7 DNA polymerase, 
Labelling Mix-dATP (1.4^iM dCTP, 1.4|iM dGTP, 1.4^M dTTP and 333.5mM 
NaCl) were added into Enzyme Dilution Buffer (20mM Tris-HCl; pH 7.5，5mM 
DTT, lOO i^g BSA/ml, 5% glycerol) and incubated at room temperature for 5 
minutes. 2.5^il of each four sequencing mix ('A', 'C', 'G', and T ' Mix-Short) was 
pre-warmed at 3 7 ¾ for at least 1 minute, and added into 4.5^1 labelling mixture and 
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incubated at 3 7 ¾ for 5 minutes. The reaction was stopped by adding 5|il Stop 
Solution. 
2.1.11.2 Thermo Sequenase Cycle Sequencing kit was purchased from 
Amersham Lf fE SCEENCE (catalog no. 78500). Cycle sequencing uses repeated 
cycles of thermal denaturation, annealing and extension/termination for DNA 
amplification. Therefore, less DNA template was required. Firstly, the primer was 
labelled by mixing 20^M primer, lO^iCi [y-P^^]-ATP or [y-P^^]-ATP, l|il 10X T4 
polynucleotide kinase buffer and 10 units of T4 polynucleotide kinase to a final 
volume of lO^il. The mixture was incubated at 3 7 ¾ for an hour. Secondly, a total 
volume of master mix was prepared in a microcentrifuge vial containing 12.5^1 of 
400ng DNA template, 2[i\ Reaction buffer (260mM Tris-HCl; pH 9.5’ 65mM 
MgCl2), 1 ^1 of Labelled primer and l|il of Thermo Sequenase DNA polymerase. 
4^il of master mix was transferred to each ddNTP (ddG, ddA, ddT, ddC Termination 
mix) tube and lO i^l of mineral oil was added into each tube to prevent evaporation. 
Thirdly, the tubes were placed in the thermal cycler (PTC-100™ Programmable 
Thermal Controller, MJ Research, Inc.). 50 cycles were performed using following 
parameters: 9 5 ¾ for 30 sec, 5 5 ¾ for 30 sec, 72°C for 2 minutes. After cycle 
sequencing, 4^il of Stop solution (95% formamide, 20mM EDTA, 0.05% 
bromophenol blue, 0.05% xylene cyanol FF) was added to each of the termination 
reactions. Samples were stored at -20^C until ready to load the sequencing gel. 
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2.1.12 Preparation of 6% Polyacrylamide, 8M Urea 
Denaturing Gel for DNA Sequence Analysis 
11.7g of urea (Sigma), 7.5ml of 40% acrylamide stock solution (38% (w/v) 
acrylamide, 2% (w/v) N,N'-methylene-bisacrylamide) and 5ml of 10X TBE buffer 
(0.9M Tris-borate, 2mM EDTA) were added to 30 ml deionized water. After all the 
urea had been dissolved, deionized water was added to make up the final volume to 
50ml. 
The Sequencing Gel apparatus was from Bio-Rad. The surface of a pair of glass 
plates was cleaned with deionized water and 70% ethanol thoroughly and were 
followed by acetone. The back plate which contacted the gel was wiped with repel-
silane thoroughly. A pair of 0.4mm thick spacers was placed between the treated 
glass plates. The bottom of the plate sandwich was sealed up by mixture of 2ml of 
polyacrylamide mixture, lO i^l of 10% ammonium persulfate and 14 i^l of TEMED 
(Bio-Rad). After the completed sealing of the bottom, the remaining 48ml 
polyacrylamide mixture was mixed with 240^il of 10% ammonium persulfate and 
38.4^il of TEMED for gel casting. Then the sandwich plate was placed at an angle 
r 
of about 20°，and the gel was poured into the gap between the plates. Great care was 
taken to prevent trapping of air bubbles inside the gel. After casting, a sample comb 
was inserted at the upper end of the plate and the sandwich plate was placed 
horizontally for setting overnight. 
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When the polymerization was complete, the comb was removed and wells were 
washed thoroughly with water to remove any remaining unpolymerized monomer. 
The gel plate sandwich was then assembled onto the gel tank. The upper and the 
lower buffer reservoirs were filled with IX TBE buffer. The gel was pre-run at 60W 
for 30 minutes. Before loading, the samples were denatured at 95^C for 5 minutes, 
and cooled immediately on ice. Then, 2^1 of sample was loaded into the well. The 
gel was run at constant power of 60W. The running time lasted for two to five 
hours, depending on the distance between the sequence of interest and the primer 
annealing site. After electrophoresis, the gel was blotted onto a sheet of 3MM 
Whatman filter paper. A piece of plastic wrap was used to cover the gel surface and 
the gel was dried in a gel dryer (Slab Gel Dryer SGD 2000，Savant). Then the dried 
gel was placed in a film cassette together with a piece of Kodak film for ovemight or 
a few days. Finally, the film was developed and the sequence was read from 5’ to 3', 
beginning at the bottom of the gel. 
2.1.13 Preparation of Escherichia coli DH5a Competent 
Cells 
r 
A single colony of DH5a was inoculated into 100ml of LB, and incubated at 37^C 
overnight until the 〇 D _ was about 0.5. The bacterial suspension was kept on ice 
for 5 minutes and the cells were collected by centrifugation at 5000 xg for 10 
minutes at 4 ¾ . Then the cells were resuspended in 40ml RF1 (30mM KAc, 
100mM RbCl2, lOmM CaCl2, 50mM MnCl2 and 15% glycerol), and kept on ice for 
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5 minutes. The suspension was centrifuged again at 5000xg for 10 minutes at 4 ¾ . 
The pellet was resuspended in 4ml RF2 (lOmM MOPS; pH 6.5, 75mM CaCl2, 
lOmM RbCl2 and 15% glycerol) and kept on ice for 15 minutes. Finally 200^1 of 
bacterial cells was aliquoted into a microcentrifuge and stored at -70¾ for future 
use. 
2.1.14 Modification of 5, Protruding end with T4 DNA 
Polymerase 
Purified DNA fragment was mixed with 10^1 of T4 DNA Polynucleotide Buffer 
(0.5M Tris-HCl; pH 7.5, O.lM MgCl2, 0.01M Dithiothreithol, 0.5mg/mI BSA), 
0.2mM dNTP, lOmM ATP, 10 unit of T4 DNA polynucleotide kinase and 10 units 
of DNA polymerase I to a total volume of lOOjil，and incubated at 3 7 ¾ for an hour. 
The reaction was stopped by 1^1 of 0.5M EDTA, and purified by Gene Clean Kit 
again. 
r 
2.1.15 Ligation and Transformation of Foreign DNA 
About 200-400ng of blunt-end DNA fragment was ligated with 50ng of pUC18 Sma 
I/BAP vector (Pharmaica Biotech) in IX ligation buffer (30mM Tris-HCl; pH 7.8， 
lOmM MgCl2, lOmM DTT and lmM ATP) containing 3 units of T4 DNA ligase. 
The ligation reaction was incubated at 16°C for overnight. Then the ligated DNA 
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fragment was transformed into 200^il of E.coli DH5a competent cells. The mixture 
was incubated at ice for 30 minutes, and placed on ice for 2 minutes immediately 
after heat shocked at 4 2 ¾ for 2 minutes. 0.4ml of LB was added into the mixture 
and incubated at 3 7 ¾ for an hour. Finally, the transformed cells were spread on 
LBA plate. The plate was incubated overnight, the white colonies were then 
screened for Rapid lysis screening. 
2.1.16 Rapid Screening for the Presence of Plasmid 
The plasmid DNA presented in the transformants were examined by lysis of single 
colonies according to Barnes (1977). The transformants were allowed to grow to 2-
3mm in size on LBA agar plate. The colony was then transferred by a sterile 
toothpick to a well of a 96-well plate containing 20|il of Rapid Lysis Buffer (50mM 
NaOH, 0.5% SDS, 5mM EDTA and 0.025% bromocresoI green). The colony was 
dispensed gently by stirring with a toothpick. Then the 96-well plate was sealed and 
incubated at 6 8 ¾ for an hour. The mixture was then loaded to a 1 % TBE agarose 
gel without the addition of EtBr. The two ends of the gel were just touching the 
running buffer. When the DNA had migrated into the gel, more buffer was added to 
submerge the gel. After electrophoresis, the gel was stained by soaking for 30 
minutes in a solution of EtBr (0.5 ^ig/ml). 
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2.2 Expression of Glycogen Synthase Kinase-3 
2.2.1 Preparation of Mammalian cells in Culture 
2.2.1.1 Preparation of Dulbecco's Modified Eagle Medium (D-MEM/F-12) for 
SHSY5Y neuroblastoma cell line in safety cabinet. All Gibco BRL cell culture 
media were purchased from Life Technologies. SHSY5Y neuroblastoma cell line 
was from Department of Neuroscience, Institute of Psychiatry, UK. 50ml of 
Qualified Fetal Bovine serum (catalog no. 26140-079), 5ml of 
Penicillin/Stretomycin mix (5,000 units of Penicillin/ml; 5,000 i^g of 
Streptomycin/ml; Catalog no 15070-063) and 5ml of 200mM L-Glutamine (Catalog 
no. 25030-081) were defrosted before mixing with 500ml of D-MEM/F-12 (15mM 
HEPES buffer, 365mg L-glutamine/L and 0.031mg pyridoxine hydrochloride/L). 
2.2.1.2 Preparation of Dulbecco 's Modified Eagle Medium (D-MEM) high 
glucose medium for A43J human squamous carcinoma cell line in safety cabinet. 
r 
All Gibco BRL cell culture media were purchased from Life Technologies. A431 
cell line was from Dr. T.D. Kwok. 50ml of Fetal calf serum, 5ml of 
Penicillin/Stretomycin mix and 5ml of L-glutamine were defrosted before mixing 
with 500ml of D-MEM high glucose medium (4.5g D-glucose；^，4mg pyridoxine 
hydrochloride/L, no L-glutamine, sodium pyruvate, L-methionine, or L-cystine). 
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2.2.1.3 Preparation of SHSY5Y/A431 cell culture 
2 X 10^  of cells were plated on the 25 mm^ flask or 60 mm culture dish containing 
2ml of culture medium. The SHSY5Y cells were incubated in a 3 7 ¾ incubator 
with 5% CO2； whereas A431 cells were incubated in a 3 7 ¾ incubator with 10% 
CO2 for about two days until the cells were 60-70% confluent. Then they were 
treated with different stresses for different times. After treatment, the cells were 
washed with cool IX PBS (Sigma) twice, and lysed by lysing buffer. The cell debris 
was removed by centrifugation at 14,000 xg for 10 minutes. Amount of protein in 
supernatant was determined by Bradford assay (Bio-Rad) (Bradford, 1976). 
2.2.2 SDS-Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
2.2.2.1 10% of SDS-PAGE preparation 
SDS-PAGE was conducted in a Mini-PROTEESf H electrophoresis cell (Bio-Rad 
Labratories, Inc.) assembled according to the manufacturer's instructions. 
10% separating gel was prepared as follows: 
Deionized water 3.96 ml 
1.5 M Tris-HCl (pH 8.8) 2.48 ml 
30% Acrylamide 3.3 ml 
10% (w/v) SDS 0.1ml 
10% (w/v) ammonium persulfate 0.1 ml 
TEMED 3.96 i^l 
3.6ml of the separating gel solution was poured into the gap between the glass 
plates. 0.5ml of isopropanol was added to keep the solution out of atmospheric 
oxygen and to remove air bubbles on solution surface. Polymerization was 
completed in 15 minutes. 
4 2 
3% of stacking gel was prepared as follows: 
Deionized water 2.55 ml 
1 M Tris-HCl (pH 6.8) 0.47 ml 
30% Acrylamide 0.64 ml 
10% (w/v) SDS 37.5 i^l 
10% (w/v) ammonium persulfate 37.5 ^1 
TEMED 3.75 i^l 
After the separating gel was set, the isopropanol layer was removed. 2 ml of 
stacking gel solution was poured and the comb was inserted to the gap between the 
glass plates. 
10|ig of protein was dissolved into IX SDS gel loading buffer (50mM Tris-HCl; pH 
6.8, 2% SDS, 10% glycerol, 1 mg Bromophenol blue/ml, and 2% p_ 
mercaptoethanol) and boiled for 2 minutes to denature the protein. Then the samples 
were applied to the wells and run at constant voltage of 150V for about 90 minutes 
until the bromophenol blue reached the bottom of the running gel. The gel was 
removed from the electrophoresis cell for Western blotting. 
2.2.3 Western Blot detection of Glycogen Synthase Kinase-3 
r 
After electrophoresis, the stacking gel was discarded. The separating gel was placed 
in the transfer buffer. A piece of 8.5X5.5 cm^ PVDF membrane (0.4jiM pore size, 
Immobilon™-P Transfer Membranes; Millipore, catalog no. ffVH 304 FO) was cut 
and pretreated with methanol , and six 9X6 cm^ 3MM filter papers were cut and 
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wetted with transfer buffer. The trans-blot® SD (Semi-dry Transfer Cell; Bio-Rad, 
catalog no. 170-3940) was set up as shown in the following diagram: 
-ve 
" ~ ^ ~ polyacylamide 
3MM filter paper -<;;^  ^ ^ ^ gel 
^ ^ \ 
ZZZZZZ=ZZZZZZI \ p V D F 
+ ve 
Constant voltage of 15V was applied for an hour for the trans-blotting. 
ECL TM Western blotting is a light emitting non-radioactive method for detection of 
immobilized specific antigens. Primary antibodies attaching to antigens on the 
PVDF membrane were detected by horseradish peroxidase-labelled antibodies. The 
maximum light emission of enhanced chemiluminescence is at a wavelength of 
428nm which can be detected by a short exposure to blue-light sensitive 
autoradiography film (Hyperfilm ECL; Amersham Life Science). The following 
procedure was modified from the method recommended by the supplier. The blotted 
PVDF paper was immersed in 5ml of TBS (with Tween-20) for a while, then non-
specific reaction sites were blocked by immersed in 5% nonfat dry milk for 30 
minutes with constant agitation. The membrane was then incubated with 0.5 |ig of 
GSK-3 primary antibody/ml (Upstate biotechnology, Catalog # 05-412，mouse 
monoclonal IgG|) or 0.5 p,g of GSK-3p primary antibody/ml (Transduction 
Laboratories, catalog no. G22320) at 4 ¾ overnight. The membrane was then 
washed with TBS (with Tween-20) 3 times for 10 minutes each. 2ml of secondary 
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antibody (1:2500 dilution) a-mouse Ig (horseradish peroxidase-linked whole 
antibody, from sheep; Amersham Life Science, catalog no. NA 931) was added and 
incubated for 90 minutes at room temperature with agitation. The blot was washed 
with TBS (with Tween-20) 3 times each for 10 minutes. Then the blot was rinsed 
with 1ml of mixture of Detection reagent 1 and Detection reagent 2，and incubated 
for 1 minute. Then the blot was exposed onto the film for 30 seconds to 5 minutes, 
and the protein level was quantified by densitometer (Personal Densitometer SI™, 
Molecular Dynamics). 
2.3 Assay of GSK-3 Promoter Activity 
2.3.1 Preparation of SHSY5Y in Culture 
SHSY5Y neuroblastoma cells were grown in D-MEM-12 medium in a 250 cm^ 
culture flask, and incubated in a 3 7 ¾ incubator containing 5% CO2 for a few days 
until the cells were 100% confluent. The cells were washed with IOml of IX PBS 
twice and trypsinized. 
r 
2.3.2 Trypsinization for Removing Adherent Cells 
The sterile trypsin-EDTA solution (0.05% trypsin, 0.53mM EDTA; catalog no. 
25300-054) was defrosted. 5ml of trypsin-EDTA was added into 250 cm^ culture 
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flask just enough to cover the cell monolayer, and the flask was rocked to evenly 
distribute the trypsin solution. The flask was placed in a 37°C incubator for 3 
minutes until the cells began to detach. 5ml of D-MEM-F12 was added into the 
flask immediately to inactivate the trypsin. Cell clumps were broken up by pipetting 
the cells up and down. The cells were counted and used for sub-culturing. 
2.3.3 Transfection of Mammalian Cells by Calcium 
Phosphate Precipitation 
The following procedure was modified according to the Profection® Mammalian 
Transfection Systems technical manual from Promega. About 4X10^ or 2X10^ cells 
were transferred to a 60 mm or 35 mm culture dish. The cells were grown overnight 
at 37°C incubator containing 5% CO2. Three hours prior to the transfection, the 
medium was removed from the cell and fresh D-MEM-F12 medium at 3 7 ¾ was 
added into the dish. Suitable amount of DNA was mixed with 2M CaCl2, and 
introduced dropwise into 2X Hepes buffered saline (HBS) with vortexing. When the 
DNA addition was complete, the solution appeared slightly opaque due to the 
r 
formation of a fine calcium phosphate-DNA co-precipitate. The solution was 
incubated at room temperature for 30 minutes and added dropwise to the cells. The 
cells were returned to the 3 7 ¾ of 5% CO2 incubator, and the culture medium was 
changed about 12 hours after transfection. Finally the cells were harvested after 48 
hours of transfection for drug stimulation. 
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2.3.4 Stimulation of transfection cells by different 
Chemicals and Preparation of Cell Extract 
For drug stimulation, the culture medium was replaced by medium containing no 
fetal calf serum a day before the experiment was carried out. Appropriate amount of 
chemical was added into freshly prepared culture medium, and the medium was 
added into cell culture for stimulation of about 30 minutes. Then the cells were 
washed with cool IX PBS twice, and lysed by 0.5ml of IX lysis buffer (5 fold 
dilution of 5X lysis buffer from ELISA kit). The cell debris was removed by 
centrifugation at 14,000xg, 4°C for 10 minutes. The supernatant was collected and 
protein concentration was determined by Bradford Assay (Bio-Rad) (Bradford, 
1976). 
2.3.5 CAT-ELISA and p-Gal ELISA Assay 
The procedure of chloramphenicol acetyltransferase (CAT) and p-Gal ELISA was 
r 
according to the manual provided by Boehringer Mannheim (Catalog no. 1363727; 
Catalog no. 1539426). The cell extract was diluted up to 150-250 i^g protein/ml by 
sample buffer, then 200^il of cell extract and CAT/p-Gal standard were loaded on a 
microtiter plate (MTP) with surface containing either anti-CAT- or anti-p-Gal-
coated antibodies, and the MTP plates were covered by a cover foil and incubated 
for an hour at 31^C. Then the wells were washed 5 times with 250^1 of washing 
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buffer for CAT-ELISA or 3 times for p_Gal ELISA. 200^il of anti-CAT-DIG/anti_p-
Gal-DIG were loaded into the well, and they were incubated for an hour at 37°C. 
The wells were then washed again with 250^1 of washing buffer as described above. 
200^1 of anti-DIG-POD were loaded into the well and incubated them for an hour at 
37^C. The wells were washed again as mentioned above. Finally, 200jil of POD 
substrate with substrate enhancer was pipetted into each well, and incubated at room 
temperature until green colour developed. The colour was measured at 405nm 
(reference wavelength 490nm) using a Microplate Reader (Model 3550, Bio-Rad). 
2.4 Isolation of Glycogen Synthase Kinase-3a 5’ 
Promoter Region 
2.4.1 5，Rapid Amplification of cDNA End (5，RACE) 
A human testis Marathon-ready cDNA was purchased from Clontech (Cat.7414-1). 
The procedure of rapid amplification of 5'cDNA ends was modified according to the 
I 
user manual. 2.5 ,^1 of ready used cDNA was amplified by PCR in total volume of 
25 ^1 reaction mixture containing 2.5|il of 10X Buffer 1 (Boehringer-Mannheim 
Expand™ Long Template PCR System, Catalog no. 1681-834; 17.5mM MgCb), 
0.4mM dNTP, 0.2^iM Adaptor primer 1 (API) (5'CCA TCC TAA TAC GAC TCA 
CTA TAG GGC3'), 0.2^iM Gene Specific primer (GSP1: AN4) (5'CTC CGC GAA 
CGA GCT AGT CC3'), and 0.5^il of 50X polymerase mix (mixture of 14.3 i^l of 
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Taq/Pow with 5.7^il of TaqStart Antibody; Boehringer-Mannheim Expand™ Long 
Template PCR System, catalog no. 1681834). The reaction was performed at 94°C 
for 1 minute, and followed by 30 cycles of 94^C for 30 seconds, 60°C for 30 
seconds, and 6 8 ¾ for 2 minutes. Then the PCR product was resolved in 1.5% TBE 
agarose, 
2.4.2 PromoterFinder DNA Walking 
Human GenomeWalker Kit was purchased from Clontech (Catalog no. K1803-l). 
Five GenomeWalker DNA libraries were used to amplify GSK-3a 5’ flanking 
region, including EcoR V, Sca I，Dra I，Pvu H, Ssp I libraries. 1 ^ il of library DNA 
was amplified by primary PCR in a total volume of 50 ^1 reaction mixture including 
5 i^l of 10X Buffer 1 (17.5mM MgCl2), 0.2mM dNTP, 0.2^iM API (5'CCA TCC 
TAA TAC GAC TCA CTA TAG GC3’)’ 0.2^iM GSP1 (AN2: 5'GAC AGA TGC 
CTT TCC GCC GC3'), and lp,l of 50X polymerase mix. The reaction was 
performed at 9 5 ¾ for 1 minutes, and followed by 35 cycles of 9 5 ¾ for 30 seconds, 
6 8 ¾ for 5 minutes, and one cycle at 6 8 ¾ for 8 minutes extension. The PCR 
product was diluted 100 folds for nested PCR. 
l^il of each diluted primary PCR product was amplified by secondary PCR in a total 
volume of 50^1 reaction mixture including 5 i^l of 10X Buffer 1 (17.5mM MgCl2), 
0.2mM dNTP, 0.2^iM AP2 (5'CTA TAG GGC ACG CGT GGT3'), 0.2^iM GSP2 
primer (AN4+: 5'TCC GCC GCC GGG CTC CGC GA3' or AN3 Rev: 5TCA TGG 
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CGC CGA GCA CAG GC3'), and 1^1 50X polymerase mix. The reaction was 
performed at 9 5 ¾ for 1 minute, and followed by 25 cycles of 95°C for 30 seconds, 
6 8 ¾ for 5 minutes, and one cycle at 68°C for 8 minutes. The PCR product was 
analyzed by 1.5% TBE agarose gel electorphoresis. 
2.4.3 YAC Clone Construction 
2.4.3.1 Isolation of Genomic DNA from YAC Clone 33A9D. A loop of fresh 
yeast cells containing YAC clone 33A9D on SDcaa agar plate (0.67% yeast nitrogen 
base，1.4% casamino acids, 2% (w/v) glucose, 50^g/ml adenine, 2% agar) was 
inoculated into 100 ml of SDcaa medium at 30°C for about two days. The cells 
were spun down at 3,000xg for 5 minutes at room temperature. 2.5ml of deionized 
water was added to resuspend the cells and 0.5ml of the resuspended cells was 
transferred to an eppendorf tube. The cell pellet was spun by centrifugation at 
14,000 xg for 5 seconds, then the pellet was resuspended in 200^d of breaking buffer 
(2% Triton X-100, 1% SDS, O.lM NaCl, lOmM Tris-HCl; pH 8.0，lmM EDTA; pH 
8.0), and mixed with 0.3g of acid-washed glass beads (425-600 microns, Sigma G-
8772) and 200^1 of phenol/chloroform. The mixture was vortexed vigorously for 3-
4 minutes, and 200|il of TE buffer was added. The aqueous phase was collected by 
centrifugation at 14,000 xg for 5 minutes. 1ml of absolute ethanol was added into 
the aqueous phase and mixed by inversion. The genomic DNA pellet was spun 
down at 14,000 xg for 15 minutes, and resuspended in 0.4ml of TE buffer. 25 jag of 
RNase A/ml was added and the solution was incubated at 5 5 ¾ for an hour. The 
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DNA was precipitated by adding lO i^l of 4M ammonium acetate, 1ml of absolute 
ethanol, and incubated at -20Pc for 15 minutes. Then, the DNA pellet was collected 
by centrifugation at 14,000 xg for 15 minutes. Finally, the yeast genomic DNA 
pellet was resuspended in 50^1 of TE buffer, and the DNA was quantified by OD260 
and OD280. 
2.4.3.2 Construction of YAC Clone Genomic Libraries by Universal 
GenomicWalkefiM Kit. The YAC clone genomic libraries were constructed 
according to the manual of Universal GenomeWalker™ Kit from Clontech (catalog 
no. K1807-l). For each reaction, 2.5^g of 33A9D DNA was digested with 10 units 
restriction enzyme/^il in suitable restriction enzyme buffer at 3 7 ¾ overnight. The 
restriction enzyme used including Dra I, EcoR I，Pvu H, Sac I’ Xho I and Nco I. An 
equal volume of phenol was added and the mixture was vortexed at slow speed for 
5-10 seconds. The aqueous phase containing DNA was collected by centrifugation 
at 14,000 xg for 5 minutes. After chloroform extraction, the aqueous phase was 
precipitated by 2 volumes of ice cold 95% ethanol, 0.1 volume of 3M NaOAc (pH 
4.5)，and 20^g of glycogen. Then the pellet was washed with lOO i^l of ice cold 80% 
ethanol’ and dried by air. Finally, the DNA pellet was dissolved in 20|il of deionized 
water. 
For each library construction, 4 i^l of digested, purified DNA was ligated with lO i^M 
Marathon cDNA adaptor (Appendix VI) in ligation buffer that contains 1 unit T4 
DNA ligase/^il. The reaction mixture was incubated at 16¾ overnight. The 
reaction was stopped by incubating at 7 0 ¾ for 5 minutes. 10|il each of the six 
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ready used YAC clone 33A9D genomic libraries: Dra I’ EcoR I，Pvu H, Sac I’ Xho I 
and Nco I libraries, were diluted to 80jal by deionized water. 
2.4.3.3 Isolation of 5’ Promoter Region by Polymerase Chain Reaction. 
Amplification of 5， p r o m o t e r region was modified from Marathon RACE reaction 
(Marathon cDNA Amplification Kit; Clontech, catalog no. K1802-l). For the 
primary PCR, 5^1 of ready used genomic library DNA was amplified in the total 
volume of 25^1 reaction mixture containing 2.5^il of 10X Buffer 3 (22.5mM MgCb 
plus detergents), 0.2mM dNTP, 0.4^iM Adaptor primer 1 (API) (5'CCA TCC TAA 
TAC GAC TCA CTA TAG GGC3'), 0.4^iM Gene Specific primer (GSP1: AN2) 
(5'GAC AGA TGC CTT TCC GCC GC3'), 0.5^1 of 50X polymerase mix. The 
reaction was performed at an initial 1 minute incubation at 9 4 ¾ , followed by 30 
cycles of 94^C for 1 minute, 5 5 ¾ for 30 seconds, 72®C for 7 minutes, finally 
incubated at 72°C for 10 minutes. 
Then’ 1^1 of ten-fold dilution of primary PCR product was used for nested PCR 
using primer API and GSP2 (AN3 Rev) (5TCA TGG CGC CGA GCA CAG 
GC3，). The reaction condition was as the same as the primary PCR reaction. The 
nested PCR products were resolved in 1.5% TBE agarose. The PCR fragments were 
further cloned in pUC 18 plasmid vector (Appendix V) and analyzed by sequencing. 
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2.5 Construction of Plasmid for Assaying of 
Glycogen Synthase Kinase-3a Promoter Activity 
pUC 18 plasmid containing 0.8，1 and 2Kb GSK-3a 5，non-coding sequences were 
digested by EcoRl and Hindm. The sticky ends were modified by T4 DNA 
polymerase, and ligated into Smal sites of plasmid pCAT3-basic (Appendix FV). 
This site is at the upstream of chloramphenicol acetyltransferase (CAT) reporter. 
Plasmid DNA containing insert was digested by Pstl and Kpnl to determine the 
orientation of the insert (Figure 2.1). 
2.6 Genomic Organization of Glycogen Synthase 
Kinase-3a 
Different regions of the GSK-3a gene in YAC clone 33A9D were amplified by PCR 
using different pairs of primers designed from GSK-3a cDNA (Figure 2.2). 50^il 
PCR reaction mixture contained 100ng of YAC clone genomic DNA, 5^1 of 10X 
Buffer 3 (22.5mM MgCl2 plus detergents), 0.4mM dNTP, 40|iM Primer 1’ 40^iM 
Primer 2, and 0.1 unit/^1 Taq polymerase. Reaction was performed at an initial 
incubation of 94°C for 1 minute, followed by 40 cycles of 94^C for 1 minute, 50^C 
for 1 minute, 72°C for 2 minute, and final incubated at 7 2 ¾ for 10 minutes. The 
PCR products were analyzed by 1.5% TBE agarose gel. Some fragments longer than 
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Figure 2.2 Glycogen synthase kinase-3a cDNA sequence. Underlined sequences indicate primer (5' 
to 3’）used for PCR. The start and stop codons are bolded. 
r 
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2.7 Primer Extension Assay 
2.7.1 Isolation of Total RNA by TRIZOL® Reagent 
(GibcoBRL Life Technologies) 
SHSY5Y cells were lysed in 1ml of Trizol Reagent, and 0.2ml of chloroform was 
added into the lysate and with vigorously shaking for 15 seconds, then incubated at 
room temperature for 2-3 minutes. The aqueous phase containing RNA was 
collected by centrifugation at 12,000 xg for 15 minutes at 4^C. 0.5ml of isopropyl 
alcohol was added into the supernatant and incubated at room temperature for 10 
minutes. The RNA pellet was collected by centrifugation at 12,000 xg for 10 
minutes at 4 ¾ , and then washed with 1ml of 75% ethanol. The washed pellet was 
air dried and finally disolved in 20 i^I of DEPC-treated water. The RNA was 
quantified by OD260 and OD280 and stored at -10PC until further used. 
2.7.2 Primer Extension by S u p e r S c r i p t T M n (GibcoBRL 
Life Technologies, catalog no. 18064-022) 
Firstly, the primer used for the primer extension reaction was labelled the 5’ end as 
in cycle sequencing (Section 2.1.11.2). 5^g of total RNA was annealed into a total 
volume of 10^1 reaction mixture containing 1^1 of labelled primer, IX First Strand 
Buffer (50mM Tris-HCl; pH 8.3，75mM KC1, 3mM MgCl2) at 5 8 ¾ for 20 minutes, 
57 
and then followed by at room temperature for 10 minutes. The lOp,l of annealing 
mixture was added into primer extension buffer that contained IX First Strand 
Buffer, 50m M DTT, lmM dNTP and 200 unit of SuperScript H RNase H" Reverse 
Transciptase, and incubated at 42^C for one hour. Finally, the reaction was stopped 




2.8 Reagents and Buffers 
2.8.1 Nucleic Acid Electrophoresis Buffers 
TAE (Tris-acetate), IX 
40mM Tris-acetate 
lmMEDTA 
TBE (Tris-borate), IX 
90mM Tris-borate 
2mM EDTA 
6X Agarose Gel Loading Buffer 
0.25% bromophenol blue 
40% (w/v) sucrose in water 
2.8.2 Reagents for Preparation of Plasmid DNA 
P1 
50mM Tris-HCl O^ H 7.5) 
lOmM EDTA 






2.55M potassium acetate (pH 4.8) 
59 
2.8.3 Media for Bacterial Culture 
LB (Luria-Bertani medium) 
10g bacto-tryptone 
5g bacto-yeast extract 
10g NaCl 
Water was added to 1 liter 
SDcaa medium 
6.7 g yeast nitrogen base without amino acids 
14g casamino acids 
50ml 40% (w/v) glucose 
Water was added to 1 liter 
Media containing agar 
Liquid media were prepared according to the recipes given above. Just 
before autoclaving, 15g ofbacto-agar was added to 1 liter liquid medium. 







lM Tris-HCl, pH 7.5 
1.5M NaCl 
60 
Transfer Buffer (20X SSC): 
175.3gNaCl 
88.2g Na-Citrate 
Adjust pH to 7.0 and make volume of 1 liter 
2.8.5 Reagents for SDS-PAGE 
2X SDS Gel-Loading Buffer 
1 ml lM Tris-HCl pH 6.8 
4 ml 10% SDS 
2 ml Glycerol 
0.02g Bromophenol blue 
0.2ml P-mercaptoethanol 
Water was added to 10ml 
SDS Running Buffer (lOX) 
30.3g Tris base 
144g Glycine 
lOgSpS 
Water was added to 1 liter and adjust pH 8.3 
Acrylamide/bis (30% T, 2.67% C) 
29.2g Acrylamide 
0.8g Bis 
Water was added to 1 liter 
61 
2.8.6 Reagents ofWestern Blot 
Transfer Buffer (semi-dry transblot) 
39mM Glycine 




0.5M Tris base 
0.6M NaCl 
TBS.T for Working 
lXTBS 
0.1% Tween 20 
2.8.7 Reagents for DNA Sequencing 









Chapter 3 Isolation of Glycogen Synthase 
Kinase-3a Promoter 
3.1 Introduction 
In order to analyze the glycogen synthase kinase-3a promoter, several approaches 
were used to isolate the 5，flanking region of GSK-3a. They include: (1) 5’ Rapid 
Amplification of cDNA end (5'RACE), (2) PromoterFinder DNA walking, and (3) 
Construction of YAC clone library. The 5'RACE and PromoterFinder genomic 
DNA walking are common methods to isolate the 5，untranslated region of cDNA. 
The two methods are quite similar, using cDNA as template in 5'RACE and 
genomic DNA in the genomic DNA walking (Figure 3.1; Figure 3.2). On the other 
hand, the YAC clone library is firstly constructed by several restriction enzymes 
digestion and followed by the genomic DNA walking technique to isolate 5， 
promoter region (Section 2.4.3). Fragments amplified from these methods were then 
analyzed and sequenced. 
The GSK-3a promoter activity can be analyzed by introducing the promoter 
fragment which is ligated upstream of the coding region of the CAT reporter gene 
(Appendix V) to generate a chimeric gene in which the putative regulatory element 
controls the expression of the reporter gene. In this study, the promoter CAT genes 
63 




RNA/DNA t'" — NNAAA -3， 








I~~^1 N N A = n 
3，- L l = — — — N N T = L ! ~ I 
AP1+ ^ 广 2 
A P 2 - , • 謝 
Figure 3.1 The flow chart of 5'RACE protocol. The fragment of 5，uncoding region 
is generated by PCR using primers API and GSP1, and followed by nested 
PCR using AP2 and GSP2. 
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£boR V Library Genomic DNA fragment as template 
Sca I Library 
Dra I Library ^ G ^ ! 
P^ II Library 5 | ^ ~ ~ i j j j y j M ^ g j y ^ j ^ ^ | | | | i | � � “ i i ����� wMM~l N 
细 I Library W H — ^ M " ^ _5， 
API “ I 
AP2 ^ PromoterFinder 
c S l A P r i m a r y P C R A d a p t o r 
T 
| < , 餘 ? , ， 麟 气 > 
AP2 "“^ 
GSP2 1 Nested PCR 
T 
I ^ ^ ^ ^ ^ M 
I 
Figure 3.2 The flow chart of PromoterFinder genomic DNA walking. The 
5，untranslated region is generated by Primary PCR, followed 
nested PCR. 
65 
are transfected into neuroblastomer cell line SHSY5Y and the expression of CAT 
gene was then studied by CAT-ELISA assay. 
To ensure the 5，GSK-3a promoter region amplified from the YAC clone 33A9D is 
the same as that in the human genomic DNA, different pairs of primers flanking the 
5，GSK-3a promoter region were used to amplify fragments in 33A9D and human 
blood genomic DNA. In the course of this study, the genomic structure of GSK-3a 
was also resolved by PCR using different pairs of primers designed from the cDNA. 
3.2 Results 
3.2.1 5，RACE 
A 850bp fragment was amplified by 5'RACE using API (5'CCA TCC TAA TAC 
GAC TCA CTA TAG GGC3') and gene specific primer 1 (GSP1) (AN4: 5'CTC 
CGC GAA CGA GCT AGT CC3') primers (Figure 3.3A). The fragment was cloned 
into pUC 18 and .sequenced. The sequence was further analyzed in GenBank. The 
result shows that it is not GSK-3a, but human RNA polymerase H 23 KDa subunit. 
Comparing the primer sequence (AN4) to the RNA polymerase H subunit sequence, 
































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































3.2.2 PromoterFinder DNA walking 
Several fragments were amplified by PromoterFinder DNA walking. A 1.2, 1.5 and 
0.9Kb fragment were amplified in the Sca I, Dra I and Pvu H libraries, respectively 
using AP2 and AN3 Rev primers (Figure 3.4A). A 0.7, 1.7 and 1.5 Kb fragment 
were also amplified in the EcoR V’ Sca I and Dra I libraries, respectively using AP2 
and AN4+ (Figure 3.4B). The fragments were further cloned into pUC 18 vector 
and sequenced. The sequences were analyzed by GenBank, they were found to be 
not GSK-3a(Table3.1). ‘ 
Table 3.1 Sequences analyzed by GenBank. The sequence of fragments are shown 
on Figure 3.5. 
Fragments generated by PromoterFinder Data analyzed by searching GenBank 
DNA walking method 
(a) chromosome 16 BAC clone 
(b) p65 subunit of transcriptor NF-kappa B 
- （c) polycystic kidney disease-associated protein 
(d) unknown sequence 
r 
(e) BAC clone 7E17 from 12q, HTGs phase 3 
















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































3.2.3 YAC clone library construction 
3.2.3.1 Southern blotting 
YAC clone 33A9D containing GSK-3a genomic DNA was used to isolate the 5’ 
GSK-3a promoter. To ensure the 33A9D clone contains sequence upstream of 
GSK-3a coding region, 33A9D genomic DNA was digested with Nco I，Xho I’ EcoR 
I and Hind III，respectively, and southern blotted by GSK-3a cDNA and a 88bp 
(from +99 to +185 denoted in the cDNA) N-terminal fragment as probes (Figure 
3.6). Cutting with Nco I and Xho I gave a 6.5 and 8Kb fragment, respectively 
(Figure 3.6B). Since there are recognition sites of Nco I and Xho I at positions +278 
and +299 on GSK-3a cDNA, the results strongly indicated that the 33A9D YAC 
clone contains at least more than 6Kb genomic fragment upstream of the 5，GSK-3a 
coding region. 
3.2.3.2 Isolation of sequence upstream of GSK-3a region 
from YAC clones using PromoterFinder DNA walking 
To amplify sequence upstream of GSK-3a, primary PCR was carried out on six 
YAC clone libraries generated from Dra. I’ EcoR I, Pvu H, Sac I，Xho I and Nco I 
restriction digestion. The primers used were API (5'CCA TCC TAA TAC GAC 
TCA CTA TAG GGC3') and AN2 (5'GAC AGA TGC CTT TCC GCC GC3'). 

























































































































GCA CAG GC3') primers. A 0.7Kb fragment was amplified in the Dra I library, 
and a 0.7 and 2Kb fragments were amplified in the Pvu H library after nested PCR 
(Figure 3.7). They were cloned in pUC 18 and sequenced. 
3.2.3.3 Sequences of 5，GSK-3a promoter 
Comparing the sequence isolated from 33A9D to GSK-3a cDNA, they are identical 
for 114bp (+1 to +114) (Figure 3.8). The sequence of the 0.7Kb fragment is from -
453 to +114, whereas the 2Kb fragment is form -1878 to +114. 
L y f - 1 
- 1 8 7 8 CTGGCTTCCT TATTTTTGGC TTTCCGGGAT CTTGTAATTT AGGAAGCGGA 
SRY 
- 1 8 2 8 GGATGCAAAA CACAAGAGTG GGAGGCCCGG TGCCGTGGCT CAAGCCTGAA 
- 1 7 7 8 ATACCAGCAC GTTGGAGGCT GAGGTAGAAT CGCTTGAGCC CAGGAATCGG 
- 1 7 2 8 AGACCGGCCT GGGCAACATG GCGAAGCCCA CCCCGCTACC CCCCACCACC 
SRY 
- 1 6 7 8 CCAAAAAACA AACCAAACCA AATTAGCTGG GCGTGATGGT GCACGCCTGT 
5 E F 1 M Z F 1 
- 1 6 2 8 AGTCCCACCT ACATGGGAGG CTTAGGTGGG GGGATTGCTT GAGCCTGGGA 
A P 2 
- 1 5 7 8 GTTAGAGGCT GCAGTGACCT GTGATTGCGC CACTGCCCGC CAGCCTGGGC 
SRY I R F 1 
- 1 5 2 8 GGCAGAGCGA GACCCTGTCT CAAAACAAAC CAAAAACTGA AAACTGAATG 
c - E t s ~~‘ “ 
- 1 4 7 8 GTGGTTGAAG ACAGGATTTT T T T T T T T T T G AGACGGAGTC T C A C T C T T T T 
E 2 F 
- 1 4 2 8 CGCCCAGACT GGAGTGCAGT GGCGCGATCT CGGCTCACTG CAACCTATGC 
- 1 3 7 8 CTCCCGGGTT CAAGCGATTC TCCTGCTTCA GCCTCCTGAG TAGCTGGTAT 
- 1 3 2 8 TACAGGCGCC CGCCACCACA CCCGGCTAAT T T T T G T A C T T TTAGTAGAGA 
N F 1 A P I 
- 1 2 7 8 CGGGGGTTTC GCTATGTTGG CCAGGCTGGT CTCGAACTCC TGACCTCGGA 
N k x 2 
- 1 2 2 8 TGATCCGCCA GCCTCGGCCT CCCAAAGTGC TAGGATTACA GGCGTGAGCT 
N F 1 A P I 
- 1 1 7 8 ACTGGCGCCC AGCCTGAGCC ACAGTGCCAG GCCCAGAAAT GACATTTCCG 
A P 4 
- 1 1 2 8 T C T T T T T A A T GCTCCATTCA GCTTCCTGGT GCGAACCACA TTGCTAGGAA 
73 
-1078 AAGCTAGACT GTATCCGAAG ACTAGTCAGT GTTCTGAGAA ACCGCCGGGA 
MZF1 
-1028 ACTTTGTTTC CCGAATCTTT GCAGAGTTGC GGTTAGAGAG GGGACATTTT 
E l k l 
-978 TTCTTTCCTG ATCTATCGGT CACCTGGAAC TTAAAGGTGC TTGGATCCAT 
A P 4 
- 9 2 8 TTTCCAGCAG TCCTTGATCG ACCTCGGCTC TTTCTTAAAG AAGGACCTGG 
NFKp 
-878 GGGCGAGGAA GGAGGCGCTG AAACACTTTT AAGTCTCTCC AGGGAACTGC 
5EF1 CAAT 
-828 CGCAGTCTCT AACCTTTCGT TCACACGCCC TGATGGTGGC^ CATTGGACTT 
S T A T x 
-77 8 CGCTTCCCGG CAAGCCTCCG CAGACTGGCC TCACAGAGGG TCAGGTCTGG 
- S p l 
-728 ACTACTCCCC AGCATGCTTG GAGCTCATGG GCGATCCCGC CCCCTCAGTC 
M Z F - 1 S T A T x 
- 6 7 8 AATGGGGAGG ATACGTCGAA CTCCATTTCC CAGAACACAC CAGGGCTCGC 
S T A T x 
-628 TGTGGCAACT GCACTGAGGC CTTGGTGCTG ACTACACTTC CCGGCAGGGA 
- 5 7 8 CTGCGGCCCA GCGTACCTGG AAAGAGGAGC GCGTAAACCT ACTCCATTTC 
C-Ets_ 5EF1 USF 
-528 CTCGCCCATC TCCGGAACTG CAGTATCCAC CTGGGGCTTA AAAACCACCT 
5EF1 
-478 GAGACTCCAT TTCCCGGCGT GCTTTAAAAA TCGCTTTACA CCTGCAATGC 
- 4 2 8 GGTGAGGGCG TGGCGACGAC TCCATTTCCC GGCTTGCCTC ACGGCCCGAG 
- 3 7 8 ACCCGCAGTT TCACGCGGGC CGACTCAATT TCCCAGAGCG CACCGGGCTC 
L y f - 1 
- 3 2 8 TGGGAGGCAT ACACAGCTAA TAGACTGAGT GAGTGGACTC CGTTTCCCAG 
N k x 2 
- 2 7 8 CGTGCATCAG GCTCTCTGCT TCCTAAAGTG CTTCAGGGCT CCCCGTCG^ 
YY1 
- 2 2 8 ^GTCGGCTG ACAGATTACC CTGGACTCCA TTTCCCGACG TACAGCGTGA 
- 1 7 8 CCCGTCATTC CCGCCCATCA TTCCCGCGGT CTACTCTGAG G C T T T T G T c S 
-128 ACTTCATTCC CCGGCGTGCC ACGCGGCTCT CTGTGCGGGC CGAGGGCGGT 
- 7 8 GACGGCGGCG CGGACGACAG CCGGACTGCA TCTCCCGGCG TGCCCCGCGG 
+1 
- 2 8 CGGGCGCTGG GCCGGAGCCG GAGCCTAAGC CGAGAGCGGC GCGGCCTGGA 
AGAGGCCAGG GCCCGGGGGA GGCGGC6GCA GCGGCGGCGG CTGGGGCAGC 
CCGGGCAGCC CGAGCCCCGC AGCCTGGGCC TGTGCTCGGC GC 
Figure 3.8. Nucleotide sequence upstream ol' lhc GSK-3a coding region (IVom +114 to -1878). Thc 
bold sequence is identical to the GSK-3a cDNA sequence. TATA is indicated by double 
line. CACCC sequences are indicated by dotted line. The predicted Pol II promoter region 
is italiced and bolded. The arrow at -129 indicates the transcriptional initiation site. Some 
predicted DNA-binding sites for transcriptional factors arc found by lhc PromolcrScan 












































































































































































































This sequence was analyzed by DNASIS Version 7 (Hitachi Software Engineering 
Co. Ltd., 1984，1991) and the PromoterScan program (TFSEARCH version 1.3; 
Yutaka Akiyama, Kyoto University 1995). The promoter sequence showed about 
58.7% GC content (Appendix I) and its restriction mapping is shown in Appendix TT. 
Some transcriptional factors and regulators were predicted by TFSEARCH. A 
TATA-like element was found at site -230 to -227 and a YY1 site was found just 
downstream of TATA box at -191. The predicted Pol II promoter region was 
between -218 to -467. An inverted CCAAT box was found at position -778，one 
Spl consensus sequence at position -685, one USF site at position -474. Three 
CACCC regulatory elements, which are known to be important for p-globin gene 
expression (Myers, et al., 1986), were found at positions -1696, -1678 and -1599. 
Other transcriptional regulatory elements including three SRY sites at positions -
1815, -1664 and -1497; four 5EF1 at positions -1616, -810, -494 and -433; three 
MZF1 at positions -1505, -985 and -671; three STATx at positions -767, -644 and -
583; two NF1 sites at position -1162 and -1131; two Nkx2 at positions -1220, -249; 
two API at -1131 and -1230; two AP4 at -1103 and -917; two c-Ets- at -1458 and -
509; two Lyf-1 at -1836 and -322; AP2 at -1534; KF1 site at -1486; Elkl at -946; 
NFKP at -828; E2F at-1424. 
To ensure the GSK-3a upstream fragment found in 33A9D can also be found in 
human genome, four different regions flanking at the 5，end were amplified by PCR. 
The results show that the fragments amplified in 33A9D are identical to those in 





























































































































































































































































































































































































































3.2.4 Primer Extension Assay 
To localize the precise trancriptional initiation site, three primers were used for 
primer extension assay. They were: AN3-Rev at +118 of the cDNA (5'TCA TGG 
CGC CGA GCA CAG GC3，），GSK-3aPl at -36 of untranslated GSK-3a promoter 
(5，AGA TGC AGT CCG GCT GTC GT3') and PEA2 at +13 between the cDNA 
and its 5’ untranslated region (5'CCG CTC TCG GCT TGG GCT3') (Appendix HI). 
The results show that the transcriptional starting site for GSK-3a was at-129 (Figure 
3.8;Figure3.10; Figure3.il). 
3.2.5 Assay of GSK-3a Promoter Activity using CAT-ELISA 
To assess the transcriptional activity of the 5，flanking fragment, several 
chloramphenicol acetyltransferase (CAT) reporter plasmid constructs were 
generated. Six fragments of the promoter from -1878 to + 114 were subcloned 
upstream of a CAT reported gene (Figure 3.12). These constructs were transfected 
by calcium chloride precipitation into neuroblastoma cell line SHSY5Y, together 
with a plasmid encoding p_gal (pSVp_gal) for normalization. A CAT reporter gene 
containing no insert was used as a basal control. 
The result shows that the lK+ sense strand (-831 to +114) construct had about 650 
folds higher CAT activity compared to the promoterIess control plasmid (pCAT3-































































































































































































































































































































































































0.8K + I CAT 
+114 -685 
0.8K _ I CAT 
-831 +114 
l K + I CAT 
+114 -831 
lK - 1 “ CAT 
-1878 +114 
2K + CAT 
+114 -1878 
2K _ “ CAT 
F — e 3.J2 GSK-3a promoter constructs. Different 5’ flanking fragments of 0.8, 1 and 2Kb were 
inserted into 5’ upstream of CAT gene of pCAT3-Basic vector. Control contained no 
insert. + indicates the sense strand of GSK-3a promoter, where - indicates the anti-sense 
slrand of the GSK-3a promoter. CAT, chloramphenicol acetyltransferase reporter gene. 
81 
lK+ (Table 3.1). Deletion of 146bp (-685 to +114 construct) sense strand (0.8K+) 
led to reduced promoter activity to about 47% and the anti-sense strand (0.8K-) 
reduced to 16%. However, the promoter activities of 2K+ and 2K- constructs (-1878 
to +114) were low, only 50 folds and 17 folds higher than the control, and about 8% 
and 3% of lK+, respectively (Figure 3.13; Table 3.1). 
Table 3.1. GSK-3a promoter activity in SHSY5Y 
Plasmid constructs Relative CAT activity * % of relative activity** 
pCAT3-Basic 0.045 + 0.031 0^6 
pCAT3-0.8K+ 13.32土2.52 47 
pCAT3-0.8K- 4.51±1.06 16 
pCAT3-lK+ 28.23土8.1 100 
pCAT3-lK- 15.39土2.99 55 
pCAT3-2K+ 2.23土1.33 8 
pCAT3-2K- 0.76土0.77 3 
r 
* CAT activities were the average (+SE) of five independent sets of experiment. 
** CAT activity in lK+ construct is defined as 100%, the % of relative activity in 

















































































































































































































































3.2.6 Genomic Structure of GSK-3a 
The genomic structure of GSK-3a was resolved by amplification of PCR using 
different pairs of primers (Figure 3.14). Comparing the length of flanking region of 
cDNA to the fragments amplified by PCR, showing that there were at least ten 
introns in the GSK-3a gene, and no intron was found at both the 3，and 5，ends 
(Figure 3.15). The approximate intron sites are shown on Figure 3.16. The 
approximate size of the GSK-3a gene is 12Kb. 
The genomic DNA fragments were then sequenced and some of the intron-exon 
junctions were determined (Table 3.2). Fragment region between between primers 
AN12 and C5 Rev (from +585 to +1179) was sequenced (Figure 3.17). Five introns 
were found and consensus sequence of GT and AG were also found in intron-exon 
junctions. And some Alu sequences were also found in the introns. 
Table 3.2 Intron-exon junctions of the human glycogen synthase kinase-3a gene 
cDNA — bitron size 
position Intron ExonAntron Intron/Exon ^p} 
a ^ ca. 2000 
585 b 5'GGTTCAAG/gtagctta...ccctca^/AACCGAGA3 ‘ * ca.2500 
669 c 5'GCGAGAAG/gtgagata..ccctgcag/AAAGACGA3 ‘ 140 
780 d 5'ATFTCAAG/gtaagcca...cgccgcag/GTGTACAT3 ‘ ca.l300 
911 e 5'TTTGGCAG/2_^gggccL.t:cccac^/TGCAAAGC3' 91 
1018 f 5'CATCATCG/2^cagagLcccctc^/ATGTTTGG3' ca.900 
1116 g 5'TCATCAAG / £ ^ g a g g g g m C t t t a c^/GTGCTGGG3' 77 
1212 h 5'GGACAAAG/£tggggca...tccctc^/GTGTTCAA3 ‘ 600 
1399 i 5 ‘ TGCTGGTG/gtgcgggc... 350 
1492 j 5 ‘ CTCACAAG/gtaagtgg...cccaggag/CTTTAACT3 ‘ ca. 900 
* Intron and exon sequences are shown in lowercase and uppercase letters, 
respectively. The 5’ donor GT and the 3’ acceptor AG are underlined. The sizes 
of intron are indicated by basepairs. 
84 
+ 1 AN1 




















































































Figure 3.14 Glycogen synthase kinase-3a cDNA sequence. Underlined sequences indicate primer (5， 



























































































































































































































































































































































































































































































































































































A N 1 2 
• 
5 ‘ ACCGAGAGCTGCAGATCATGCGTAAGCTGGACCACTGCAATATTGTGAGGCTGAT 
























, -C5 Rev +1179 
r 
Figure 3.17 Sequence of introns between AN12 and C5 Rev (from +585 to 1179) of the cDNA. The 
consensus sequence of GT and AG found in intron-exon junction is underlined. Some Alu 
sequences are double-lined. The primers are indicated by arrows. The exons are bolded. 
89 
3.3 Discussion 
3.3.1 Glycogen Synthase Kinase-3a Promoter 
5'RACE and PromoterFinder DNA walking are commonly used to amplify 5’ or 3’ 
terminal regions. Several fragments but not GSK-3a promoter region were 
amplified by these methods. One of the sequences isolated was RNA polymerase 
subunit. The AN4 primer used in 5'RACE was 80% identical to the sequence of 
RNA polymerase subunit (Figure 3.3B). This shows some primers used in 5'RACE 
and PromoterFinder DNA walking method may not be gene specific. Besides, as the 
human genome is complex, it is easy to obtain a false positive sequence. Further, 
the 5' coding region of the cDNA is very GC rich, this has also hindered the 
choosing of primer binding site. 
YAC clone 33A9D has been found to contain GSK-3a gene. By southern blotting, 
the existence of an upstream sequence was confirmed (Figure 3.6B). Therefore, a 
series of genomic libraries was constructed from the YAC clone. A 2Kb GSK-3a 
promoter region was eventually amplified. This DNA fragment was sequenced and 
fused to a CAT reporter gene and transfected to a neuroblastoma cell line SHSY5Y. 
Sequence analysis of the promoter fragment from PromoterScan service revealed the 
presence of consensus elements for transcription factors, e.g. TATA, YY1, Spl and 
USF. The approximate Pol H promoter region was predicted between position -467 
to -218, and the transcriptional initiation site was localizated at -129. However, 
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some minor bands found in the primer extension assay at site -120, -121, -122, -123 
are likely an incompleted by reverse transcriptase due to the methylated nucleotides 
of the 5'-cap of eukaryotic mRNA (Figure 3.11). A TATA box found at position -
230 to -227 may play a role in transcriptional start, and YY1, which was found at the 
upstream of 36bp from TATA box, may bend DNA and act as a stimulator or 
repressor of nearby sites. Besides, the presence of Spl and USF may associate with 
transcription activation, since they are activators commonly found in many 
promoters and enhancers (Kadonaga, et al., 1987; Wimmer, et al., 1993; Natesan, et 
al., 1993). 
Comparing with human CDK2 promoter, a YY1 box at -13 is also found the 
upstream from the three transcriptional start sites which located at position +1，-5， 
and -9; whereas a YY1 box found at -189 in GSK-3a promoter, which is just about 
60bp upstream of start sites. 
Other transcriptional regulatory elements STATx were also found. STATx are 
activated by tyrosine kinase membrane receptor (JAK1, JAK2, JAK3 and TYK2) 
signals which induce phosphorylation, receptor ligands include ffN, EGF, growth 
hormones, etc (Zhong, et al., 1994a; Zhong, et al., 1994b; Seidel, et al., 1995). For 
studying the transcriptional regulation of GSK-3a, previous study showed that 
insulin can cause reduction of the levels of GSK-3a mRNA by altering its stability, 
and higher GSK-3a mRNA level was found in diabetic livers (Rao, et al., 1995). 
However, it is not known if other growth factors, such as epidermal growth factor 
(EFG) and insulin-like growth factor (IGF), may influence GSK-3a mRNA level. It 
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is known that in the post-translational regulation, GSK-3 is inactivated by insulin 
(Sutherland, et al., 1993; Welsh and Proud, 1993), and also EGF and IGF (Saito, et 
fl/” 1994) by phosphorylation. Therefore, the investigation of EGF, IGF or other 
growth factors on GSK-3a mRNA is necessary for further study. 
API and AP2 sites were found in GSK-3a 5，flanking region at position -1230,-
1131 and -1534，respectively. API site is bound by ubiquitous factors, such as Fos, 
Jun，JunB, JunD, and responds to phorbol ester (TPA) and protein kinase C (PKC). 
AP2 site is class I enhancer, and is induced by TPA, PKC, cAMP and ras gene. 
Although it is not known if TPA, PKC or cAMP may directly regulate GSK-3a at 
the transcriptional level, presence of API and AP2 regulatory elements in GSK-3a 
may be influenced by these factors, and hence regulate the expression of GSK-3a 
mRNA. An c-Ets binding site, recently found to act as a negative element in EL-2 
promoter (Romano-Spica, et al., 1995)，was also found in GSK-3a promoter at -
1458 and -509. 
3.3.2 Glycogen Synthase Kinase-3a Promoter Activity 
To evaluate the GSK-3a promoter activity, six genomic constructs of different 
lengths expanding from -1878 to +114 were analyzed in SHSY5Y cell line. The 
results show that the sense strand had higher promoter activity than the anti-sense 
strand. Usually, only one strand has promoter activity. Li examples for the 
promoters of human polo-like kinase (Plk), cyclin-dependent kinase-2 (CDK2) and 
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DNA-protein kinase (DNA-PKcs), no activity was observed in the antisense strand 
(Brauninger, et al., 1995; Shiffman, et al, 1996; Connelly, et al., 1998). Here the 
1K+ sense strand showed the highest promoter activity, and its activity of anti-sense 
strand (lK-) was reduced to 55%. Analyzing the 146bp fragment between 0.8 and 
1Kb fragment found that there is a Spl site and an inverted CCAAT box at position -
685 and -778, respectively. The presence of the inverted CCAAT box may explain 
why the anti-sense strand of 1Kb fragment had the moderate promoter activity of 
about 55%, which was slightly higher than 0.8Kb sense strand promoter construct. 
It is also possible that there is a gene transcribed in the opposite orientation. The 
bidirectional promoter arrangment is also found in DNA-PKcs gene, in which a 
MCM4 gene is found to be about 700bp upstream of DNA-PKcs, and MCM4 gene is 
transcribed in the opposite direction to DNA-PKcs (Connelly, et al., 1998). 
However, the presence of an other gene in GSK-3a promoter region need to be 
further confirmed. 
Interestingly, the 2Kb promoter construct showed a 12-18 folds lower of promoter 
activity compared to the 1Kb construct. It seems that there are some inhibitory 
sequences or silencers 5，upstream of the promoter (-1878 to -831). Several 
transcription regulatory fragments found in GSK-3a, such as API, AP2, c-Ets might 
down regulate the promoter activity. Besides, if presence of bidirectional promoter 
was trueIy in GSK-3a promoter region, the decrease of promoter activity in 2Kb 
long may be due to the interference between the two promoters (Connelly, et al., 
1998). 
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In short, there are several putative transcriptional regulatory elements in GSK-3a 
promoter. They may be regulated by different cell stimulations, for example, growth 
factors and stresses and further study on the role of these factors is needed. 
3.3.3 Prospective and Future Studies 
A 2Kb GSK-3a promoter has been isolated and sequenced. A precise transcriptional 
initiation site is located at -129 by primer extension assay. One of the future 
direction of research is to determine the binding site of RNA polymerase E using 
RNase protection assay. 
Besides, in order to understand the transcriptional regulation of GSK-3a promoter, a 
series of mutation or deletion of the 2K promoter constructs should be established to 
evaluate the promoter activity. For examples, the promoter activities would be 
analyzed in a region without transcriptional starting site at -129; a region without 
TATA box; a region just after TATA box sequence; a region after predicted Pol H 
promoter binding region (-467 to +114) 
Since our results show that the 2Kb promoter fragment had the lowest promoter 
activity, and it may due to the presence of some inhibitory binding sites between -
1878 to -831 region. Different deletion mutants between this region should be 
established and their promoter activities should be assayed, to investigate the 
localization of the inhibitory binding sites that influence the promoter activity. 
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Previous studies showed that GSK-3a mRNA is inactivated by insulin (Rao, et al., 
1995)，and some of the transcriptional regulatory fragments such as STATx, API 
and AP2 that would response to it. So that another further study of the GSK-3a 
promoter activity may involve several treaments such as insulin, IGF-1, TPA, 
okadaic acid and tyrosine phosphatase inhibitors on cell lines transfected by GSK-3a 
promoter linked to a reporter gene. 
At least ten introns have been found in the GSK-3a gene, only part of intron-exon 
boundaries of the genomic gene have been resolved. The remaining intron-extron 








Chapter 4 Express ion of Glycogen Synthase 
Kinase-3 
4.1 Introduction 
According to Yang's study (Yang, et aL, 1996a; 1997)，the heat stress (46¾) can 
induce an increase in the protein level of GSK-3a to about 200% of control (no 
stress), and also induce an increase of activity to about 300% of control. It is 
suggested that heat stress induces an increase expression of GSK-3a at 
transcriptional level. 
Recent study found that stress-activated protein kinase (SAPK), which is widespread 
in brain (Carletti et al., 1995)，also phosphorylates tau in vitro at threonine^^^ and 
serine422 which are more highly phosphorylated in Alzheimer tau (Reynolds, et al., 
1997). And lithium has been shown to reduce the phosphorylation of tau by 
inhibiting GSK-3 in human NT2N neurons (Hong, et al., 1997b). 
Since both GSK-3 and SAPKs are able to phosphorylate tau in vitro, and other 
studies has shown that SAPKs can be activated by cellular stresses such as heat, 
sorbital，actinomycin, UV, sodium arsenite, etc (Zanke, et al, 1996). So, that 
another aim of my study is to investigate the expression of GSK-3 by several 
stresses, including thermal shock (46^C), sorbital and lithium in neuroblastoma cell 
line (SHSY5Y) and human squamous carcinoma A431. 
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4.2 Results 
Expression of GSK-3 under Stresses 
The expression of GSK-3 was analyzed in both SHSY5Y and A431 cell lines which 
were stressed by heat shock (46¾), 40mM sorbitol and 20mM LiCl, respectively, at 
different time courses (0-1 hour). GSK-3a and -3p were detected by Westem 
blotting by anti-GSK-3, and the level of protein was determined by densitometer. 
The result shows that GSK-3a had slower electrophoretic mobility (51KDa) 
compared to GSK-3p (47KDa). GSK-3p protein level increased more rapidly than 
GSK-3a after 30 minutes heat shock in SHSY5Y (Figure 4.1), but showed not much 
different in A431 cell line (Figure 4.4). GSK-3 protein level decreased after 30 
minutes sorbital stress in SHSY5Y (Figure 4.2), but also not much change in 
A431(Figure 4.5). And a increase of protein level of GSK-3a to 2.5 fold and GSK-
3p to six fold, respectively after 30 minutes after 20mM LiCl treatment in SHSY5Y 
(Figure 4.3). Since previous studies showed that lithium inhibits human GSK-3p 
and Drosophila Zw3'^ ® activity (Stambolic, et aL, 1996)，the GSK-3p was also 
examined by anti-GSK-3p antibody after 20mM LiCl treament, only 2 fold of 
protein level increase after incubated for 30 minutes(Figure 4.7). However, there is 
no change of protein level in A431 after lithium stimulation. In general, the 
expression of GSK-3 did not change much after 60 minutes stress by these 































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































4.3.1 Post-translation regulation of Glycogen Synthase 
Kinase-3 
The protein levels of GSK-3a and -3p were not change after 60 minutes heat shock 
(46¾), 40mM sorbitol and 20mM LiCl stimuation. The result shows that the 
expression of GSK-3 is not regulated by these agents. The slightly change of GSK-3 
expression found in LiCl treament in SHSY5Y, it might be due to inappropriate 
amount of protein loading. 
There are many reports indicating that GSK-3 is regulated post-translationally. For 
examples, tyrosine dephosphorylation reduces GSK-3 activity in vitro. When CHO-
lR cells are stimulated with TPA and insulin, GSK-3 activities are decreased about 
30% and 50%, respectively; and the phosphotyrosine content of GSK-3 also shows 
40% and 70% reduction, although the GSK-3p protein level remains the same 
(Huges, et al., 1993; Wang, et al., 1994). This phenomenon has also been found in 
COS cells stimulated by phorbol 12-myristate 13-acetate (TPA) and epidermal 
growth factor (EGF) (Saito, et al., 1994; Eldar-Finkelman, et aL, 1995). h\ addition, 
the GSK-3a activity and its phosphotyrosine content in A431 cells decrease to about 
30% of control by protein tyrosine kinase (PTK) inhibitor, typhostin A47 and B42; 
and the reactivation of GSK-3a is observed after removal of PTK inhibitors from 
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A431 cells because of tyrosine rephosphorylation. However, immunoblotting 
analysis with anti-GSK-3a antibody reveals that the protein level of this kinase in 
A431 cells does not change in the presence or absence of PTK inhibitors (Yu, et al., 
1997). 
These results taken together demonstrate that the activity and phosphotyrosine 
content of the kinase can be substantially decreased by insulin, EGF or PTK 
inhibitors, indicating that a post-translational modification of GSK-3 is in this 
inhibition process. It has been found that GSK-3 is active in resting cells and is 
tyrosine phosphorylated at position 279 for GSK-3a and at position 216 for GSK-3p 
(Hughes, et al., 1993). At present, the underlined mechanism responsible for 
tyrosine phosphorylation/dephosphorylation of GSK-3 in resting cells is unknown. 
On the other hand, the majority of current studies have shown that GSK-3 is 
inactivated in response to growth factors via phosphorylation of serine residues, 
notably Serine21 in GSK-3a and Serine9 in GSK-3p (Sutherland, et al, 1993; Saito, 
et al., 1994; Stambolic et aL, 1994). And recent data indicate that insulin/IGF-1 
induce inhibition of GSK-3p is mediated solely by the phosphorylaltion of Serine9, 
but not by dephosphorylaltion of Tyrosine216 (Shaw, et al., 1997). 
Until now, there are three models of possible signal transduction routes for the 
regulation of GSK-3, involving (1) signalling to GSK-3 by Wg involves a protein 
kinase C (PKC) (Cook, et al., 1996)，（2) insulin signalling to GSK-3 via a PI 3-
kinase-regulated step (Cross et aL, 1994; Welsh et al., 1994) and (3) signal 
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transduction to GSK-3 by EGF involves MAP kinase/p90''^ (Eldar-Finkelman et al, 
1995) (Figure 1.3). Although it is not clear what step is associate with tyrosine 
dephosphorylation. It is suggested that the inactivation of GSK-3 is likely via serine 
phosphorylation, and also tyrosine dephosphorylation in independent regulatory 
pathways, possibly involves protein tyrosine phosphatase. 
4.3.2 Prospective and further studies 
The stresses used for the expression study did not affect the GSK-3 protein level. 
No change of the protein level does not mean that is no change of the GSK-3 activity 
under different cellular stresses. The other further study is to analyze the GSK-3 
activity. Recently, new peptide substrates which are based on the sequences around 
the single GSK-3 phosphorylation sites in the translation factor eff2B, are used for 
assaying the activity in cell extracts. The eEF2B-based peptides offer important 
advantages over previous substrates, glycogen synthase (GS). In particular, 
decreases in GSK-3 activity following insulin treatment, are partially or completely 
masked when using GS-based peptides, but are readily measured using the eff2B-
based peptides. In addition, the new peptides, unlike those based on GS, without the 
need for prior immunoprecipitation or ion-exchange chromatography for the assay of 
the changes in GSK-3 activity in cell extracts (Welsh, et al., 1997). 
On the other hand, it is better to use anti-phosphotyrosine or anti-phosphoserine 
antibody instead of anti-GSK-3 antibody for analyzing the expression of GSK-3, 
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since recent studies show that addition to serine phosphorylation, tyrosine 
dephosphorylation of GSK-3 is also important for the regulation of GSK-3 activity 
in the response to extracellular signals (Yu, et al., 1997). Therefore using the 






Chapter 5 Conclusion 
Glycogen synthase kinase-3 (GSK-3), a serine/threonine protein kinase, was first 
been found to have role in regulation of glycogen synthase in 1980 (Rylatt, et al., 
1980). Later studies showed that it is a multi-substrate protein kinase, acting on 
many substrates including transcription factors such as c-jun (Boyle, et al., 1991)， 
cAMP response element-binding protein (CREB) (Fiol, et al, 1994)，eukaryotic 
initiation factor 2B (Welsh, et al., 1996; 1998)，and microtubule-associated protein 
tau (Lovestone, et al, 1994; Anderton, et al., 1995), etc. GSK-3 is widely expressed 
in different tissues. Two isoforms, termed GSK-3a and 3p, which show 98% 
identity in their catalytic domain, are found in mammals (Woodgett, 1990). GSK-3 
is highly conserved from invertebrates to mammals, it is found to be important in the 
cell fate determination in Drosophila (Siegfried, et al., 1992)，dorsoventral axis 
formation in Xenopus (He, et al, 1995; Pierce, et al., 1995) and chromosome 
segregation in Saccharomyces cerevisiae (Puziss, et al., 1994). 
r 
GSK-3 has been found present in brain neurons, and phosphorylates several neuronal 
substrates such as tau protein and neurofilament, etc. Later studies show that GSK-
3p is equivalent to tau protein kinase I (TPK I) which hyperphosphorylates tau 
protein in Alzhimer's disease brain (Ishiguro, et al., 1993). t i addition, reduction of 
GSK-3a protein level and activity have been found in Schiophrenic patient 
109 
lymphocytes (Yang, et al., 1995b)，and high amount of protein level and its activity 
are also been found in tumor cell dedifferentiation (Lee, et al, 1995; Yang, et al., 
1995c; Yang, et al., 1996b). In order to understand the transcriptional regulation of 
GSK-3, GSK-3a promoter is necessary to be isolated, and its expression studies is 
also carried out in my study. 
5.1 Promoter Study 
Three methods were used to isolate GSK-3a promoter, including 5，Rapid 
Amplification cDNA End (5'RACE), Promoter Finder DNA walking method and 
YAC clone 33A9D libraries. The fragments amplified by first two methods were not 
GSK-3a, because of the non-specific priming of the primers from the cDNA. Since 
it has been found that YAC clone 33A9D containing GSK-3a 5，untranslated region 
(Figure 3.6)，six YAC clone libraries were constructed. A 0.7Kb fragment was 
amplified from Dra I library, and a 0.7Kb and 2Kb fragments were amplified from 
Pvu II library-after nested PCR (Figure 3.7). 
The amplified DNA fragments were sequenced and analyzed by the PromoterScan 
program (TFSEARCH version 1.3). A TATA-like element is found at site -230 to -
227, and a YY1 site is found just downstream of TATA box at -191. The predicted 
Pol n region is between -218 to -467 (Figure 3.8). Besides, a transcriptional starting 
site is further been confirmed at -129 by primer extension assay using SHSY5Y 
RNA (Figure3.il). 
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Six different length of GSK-3a promoter fragments, 0.8K+, 0.8K-, lK+, lK-, 2K+ 
and 2K- were subcloned upstream of CAT reported gene, and transfected into 
SHSY5Y. lK+ plasmid construct gave the highest promoter activity, about 650 fold 
higher than the promoterless control. Sequence of this region contained YY1, USF, 
Spl and an inverted CAAT transcriptional regulatory elements, that might help to 
activate the transcription of GSK-3a. However, the promoter activities of 2K+ and 
2K- constructs were low, only 50 folds and 17 folds higher than the control, and 
about 8% and 3% of lK+, respectively (Figure 3.13). It might due to the presence of 
some inhibitory sequences or silencers at the 5，distal region of the promoter. 
5.2 Genomic Organization Study 
The genomic structure of GSK-3a was resolved by amplification of PCR using 
different pairs of primers. There were at least ten introns found in the GSK-3a gene, 
and no intron was found neither at the 3’ or 5’ ends (Figure 3.15; Figure 3.16). 
Approximately, there was about 12Kb long of the whole GSK-3a genomic DNA. In 
addition, region between primers AN12 and C5 Rev (from +587 to +1179) was 
sequenced. Five introns were found, and the consensus sequence of GT and AG 
were also found in intron-exon junctions, and some Alu sequences were also found 
in the introns (Figure 3.16; Figure 3.17). 
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5.3 Expression Study 
The protein level of GSK-3 was assayed by western blotting under different 
stimulations in SHSY5Y and A431 cell lines, including heat shock (46¾), sorbital 
and lithium. However, there is no change of the protein level in both GSK-3 
isoforms after 60 minutes stimulation. The results shows that the expression of 
GSK-3 is not regulated by these agents. 
In my study, a 2Kb fragment of GSK-3a promoter is isolated from the 33A9D, and 
the transcriptional starting site is found at -129 which is about 97bp downstream of 
TATA box. lK+ plasmid construct shows the highest promoter activity. Besides, at 
least ten introns are found in the GSK-3a gene, and it is approximately 12Kb long of 
the whole genome. However, the investigation of the expression of GSK-3 under 
different cellular stresses shows that there is no change of protein level in both GSK-
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0 + + + + + + + + 
9 8 0 9 9 0 1 0 0 0 1 0 1 0 1 0 2 0 1 0 3 0 1 0 4 0 1 0 5 0 
-898 TTTCTTAAAGAAGGACCTGGGGGCGAGGAAGGAGGCGCTGAAACACTTTTAAGTCTCTCCAGGGAACTGC 
100% + + + + + + + + 
I 
80十 
I * * **• **• *** 
50 +• • • *•*• I •**• • I * • •• ••*• ***•* 
I _* + *** *** •*-*• *_•_*• + + + 
4 0 + * • * * I * * * * * • * * * I 
i * *•• * • I 
2。T I I 
0 十 + + + + + 十 十 
1 0 5 0 1 0 6 0 1 0 7 0 1 0 8 0 1 0 9 0 1 1 0 0 1 1 1 0 1 1 2 0 
-828 CGCAGTCTCTAACCTTTCGTTCACACGCCCTGATGGTGGCCATTGGACTTCGCTTCCCGGCAAGCCTCCG 
100% + + + + + + + *--- + 
I ! I 
80 + i * ** I 
I * * * * * * * * * 
60 +**•**•** * * * * * * * * * * **** * **** * I I 
I **•_*_* **_*_*_*_***_* *_**_*_****** *-- + + 
4 0 十 * * * * I 
I I 
2 0 + I 
I I 
0 + + 十 + + + + + 
1 1 2 0 1 1 3 0 1 1 4 0 1 1 5 0 1 1 6 0 1 1 7 0 1 1 8 0 1 1 9 0 
-758 CAGACTGGCCTCACAGAGGGTCAGGTCTGGACTACTCCCCAGCATGCTTGGAGCTCATGGGCGATCCCGC 
100% + + + + + + + + 
I I 
8 0 + 1 
I * : • … * 丨 60 +*• *** ** * * * * • * 
I __* **•* *•*_••__*****__ + __* ***__*_* + •***_•*_**• 
4 Q 十 * • * * « * * I * * * * * * * * * • 
I * ** 
2 0 + 
I 
0 + + + + + + + + 
1 1 9 0 1 2 0 0 1 2 1 0 1 2 2 0 1 2 3 0 1 2 4 0 1 2 5 0 1 2 6 0 
-688 CCCCTCAGTCAATGGGGAGGATACGTCGAACTCCATTTCCCAGAACACACCAGGGCTCGCTGTGGCAACT 
100% + + + + + + + + 
I I I I 
80 + ** I* … 
I * * * * * * * * * * * * * 
50 +**** * * * * * * *• * *** I *** ** * * I 
I——* + *•*_*_* — + ——* + - … 
4 0 + * * * * * * * • * * * * I 
I • I 
2 0 + I 
I I 
0 + + + + + + + + 
1 2 6 0 1 2 7 0 1 2 8 0 1 2 9 0 1 3 0 0 1 3 1 0 1 3 2 0 1 3 3 0 
-618 GCACTGAGGCCTTGGTGCTGACTACACTTCCCGGCAGGGACTGCGGCCCAGCGTACCTGGAAAGAGGAGC 
131 
100% + + + + + + + ___ _ _ + 
Bo! I I 
I * * * * * * 
60 + * I * * * * * * * * ** * I * • 
I * **- + *-- + ** + *--** *--*-* + -** + __**_****i 
40 + * * *| * * * * * * * * * ** * I * |** I 
I * * * ** * * 
20 + I I ****I 
0 ！ i ！ ！ i 
1330 1340 1350 1360 1370 1380 1390 1400 
-548 GCGTAAACCTACTCCATTTCCTCGCCCATCTCCGGAACTGCAGTATCCACCTGGGGCTTAAAAACCACCT 
100% + + + + + + + ___ _ __ + 
I I I 
80 + ** I ** I 
I 丨 ** * * * * * ** * * * * I 
60 + * * * * 丨 * 1* … 
I • * * * + * - - + + ••* + •**_*••__ + + ••一 ‘ 
40 + * • • * * I * * * * * * • * 
I * * * * * * * * * I 
20 + ** * * 
I 丨* * 
0 + + + --* + + + I 1400 1410 1420 1430 1440 1450 . 1460 1470 
-478 GAGACTCCATTTCCCGGCGTGCTTTAAAAATCGCTTTACACCTGCAATGCGGTGAGGGCGTGGCGACGAC 
100% + + + + + ---* + + . 
I I " | 
8 0 + • * •• * * * * ； 
I **• * * •• * •*•*•* • • •• •• •• 
60 + … I ** * * ! * • * * * »* 
I _ * * • ^ * * + _| • • **_( * _• ’ 
40 +• * • * • * • * I 
I • * • * I 
20 + * 
I 
0 + + + + + + 1 
1470 1480 1490 1500 1510 1520 1530 1540 
-4 08 TCCATTTCCCGGCTTGCCTCACGGCCCGAGACCCGCAGTTTCACGCGGGCCGACTCAATTTCCCAGAGCG 
100% + + + + + + + 
I I I 
80 + I 
I ****** * � ** 
60 + ***|** … * ** * * * • 
I + --**-*--- + + --*-*-*****•-__*_** + *•• * + *•*_***_• + 
40 + * ****** I ** * * * I 
I • * * * * * * 
20 + * 
0 i ！ 
1540 1550 1560 1570 1580 1590 1600 1610 
-338 CACCGGGCTCTGGGAGGCATACACAGCTAATAGACTGAGTGAGTGGACTCCGTTTCCCAGCGTGCATCAG 
r 
ioo%+ + + + + + + + 
1 I I 
80 + ** I 
I * * • * * * I 
60 +• * • • I * • • * * * I * • • • 
I -*-• ** + ** + -• + "-* *• • — + *• + _• • • • + 
40 + * * * I * • • • 丨 • • … * I • … * • * * 
I *•* * * * * * * • I 
2� I I I I I 
0 + + + + + + + 1 1610 1620 1630 1640 1650 1660 1670 1680 
-2 68 GCTCTCTGCTTCCTAAAGTGCTTCAGGGCTCCCCGTCGTATAGTCGGCTGACAGATTACCCTGGACTCCA 
132 
100% + + + + + + + + 
I I I 80 + * I * * * • • * I * • * 
50 + **** • ** *** *• I * *• ** � * 
I * * * * _ • * • * * • * • * + 一 _ * • _ + * * - + _ _ * „ * • + 一 _ • 一 I 
4 0 + * * * * * * • * • * • • * • * • * **I 
I I * i 
：1 I I 
0 + + + + + + + + 
1680 1690 1700 1710 1720 1730 1740 1750 
-198 TTTCCCGACGTACAGCGTGACCCGTCATTCCCGCCCATCATTCCCGCGGTCTACTCTGAGGCTTTTGTGG 
100% + + + + + + --*** + + 
I I I I 80 + ***** ** ********* •* *** 
I * ***** **** ** I ********* *� ** » ,. 
60 + ** I ** *• I I 丨 * … • 叫 
|___* + + … - 十 + + j ； 




1750 1760 1770 1780 1790 1800 1810 1820 
-12 8 ACTTCATTCCCCGGCGTGCCACGCGGCTCTCTGTGCGGGCCGAGGGCGGTGACGGCGGCGCGGACGACAG 
100% + + + _*******• + + + + •**_ + 
I I I I I 
80 + * * * * * * * * * ******** *••*• «. •• •� 
I * * * I * *** * ***** I 
60 + * *** 丨 * ** * I 
|__**_**__ + + + + ***__***__ + I 
40 + * 
I 
20 + 
I I 0 + + + + + + + 
1820 1830 1840 1850 1860 1870 1880 1890 
-58 CCGGACTGCATCTCCCGGCGTGCCCCGCGGCGGGCGCTGGGCCGGAGCCGGAGCCTAAGCCGAGAGCGGC 
100% + + *** + * + *** + + + 
I I I I I 
80 +* * * * * * * * * * * * * * * •**•**•** •**•** * • * * * * * * * * * * •••i 
I * ** I *** � … 
60 + ** ** * I I I 
I-—***--* + + + + ! + 
4 0 + 
I 
20 + 
0 L - - : -
1890 1900 1910 1920 1930 1940 1950 1960 
+ 2 8 GCGGCCTGGAAGAGGCCAGGGCCCGGGGGAGGCGGCGGCAGCGGCGGCGGCTGGGGCAGCCCGGGCAGCC 
r 
ioo%+ 十 + +一一 
I I 80 +** *** I * * 
I * • * * * * • * * * * * * 
60 + I * **** ** 
4 � I � - - - - - * : � 
2�1 I I* 
0 + + + +--
1960 1970 1980 1990 
+ 9 8 CGAGCCCCGCAGCCTGGGCCTGTGCTCGGCGC 3“ 
133 
Appendix III 
Restriction sites of GSK-3a promoter region (From -1878 to +114): 
* • • * 
-187 8 CTGGCTTCCTTATTTTTGGCTTTCCGGGATCTTGTAATTTAGGAAGCGGAGGATGCAAAA 
^ A A A 
A l w I M n l I F o k I 
BstYI SfaNI 
E c o R I ‘ 
M f l I 
X h o I I 
-1818 CACAAGAGTGGGAGGCCCGGTGCCGTGGCTCAAGCCTGAAATACCAGCACGTTGGAGGCT 
A A A A A A 
MnlI BanIDsaI BstXI MnlI 
NlaIV MnlI 
SecI 
* * * * * * * * * * -1758 GAGGTAGAATCGCTTGAGCCCAGGAATCGGAGACCGGCCTGGGCAACATGGCGAAGCCCA 
A A A A A 









H g i A I 
* * * * * 
-1638 GCACGCCTGTAGTCCCACCTACATGGGAGGCTTAGGTGGGGGGATTGCTTGAGCCTGGGA 
A A 
A A A 
BstXIMnlI Bbvl 
SecIMnlI 
* • * * * 
-1578 GTTAGAGGCTGCAGTGACCTGTGATTGCGCCACTGCCCGCCAGCCTGGGCGGCAGAGCGA 
八 A A 
PstI SecI BsmAI 
-1518 GACCGTGTCTCAAAACAAACCAAAAACTGAAAACTGAATGGTGGTTCAAGACAGGATTTT 
^ N A 
BsmAI E c o R I , 
T t h l l . l I 
* * * * 
-14 58 TTTTTTTTTGAGACGGAGTCTCACTCTTTTCGCCCAGACTGGAGTGCAGTGGCGCGATCT 
A A A A A 
BsmAI BsmAI BsrI 
P l e I 
TthlllI 
134 
- 1 3 9 8 CGGCTCACTGCAACCTATGCCTCCCGGGTTCAAGCGATTCTCCTGCTTCAGCCTCCTGAG 
/N A A 
A v a I M n l I 
M n l I 
N s p I I I 
S e c I 
SmaI 
XmaI 
- 1 3 3 8 TAGCTGGTATTACAGGCGCCCGCCACCACACCCGGCTAATTTTTGTACTTTTAGTAGAGA 
A A 
A h a I I BsmAI 
A c y I 
B a n I 
B b e I 
B b i I I 
H a e I I 
N a r I 
N l a I V 
* * * * * • * • * 
- 1 2 7 8 CGGGGGTTTCGCTATGTTGGCCAGGCTGGTCTCGAACTCCTGACCTCGGATGATCCGCCA 
^ ^ A AA 
B a l l BsmAI A l w I 
C f r I M n l I F o k I 
E a e I S e c I 
H a e I 
- 1 2 1 8 GCCTCGGCCTCCCAAAGTGCTAGGATTACAGGCGTGAGCTACTGGCGCCCAGCCTGAGCC 
A A A A 
M n l I M n l I A h a I I 
S e c I A c y I 
B a n I 
B b e I 
B b i I I 
B s r I 
H a e I I 
N a r I 
N l a I V 
* * * * * * * * * * 
- 1 1 5 8 ACAGTGCCAGGCCCAGAAATGACATTTCCGTCTTTTTAATGCTCCATTCAGCTTCCTGGT 
A 
D r d I 
- 1 0 9 8 GCGAACCACATTGCTAGGAAAAGCTAGACTGTATCCGAAGACTAGTCAGTGTTCTGAGAA 
A A 
M b o I I 
� S p e I 
- 1 0 3 8 ACCGCCGGGAACTTTGTTTCCCGAATCTTTGCAGAGTTGCGGTTAGAGAGGGGACATTTT 
A A 
E c o R I ‘ M n l I 
135 
**** ***** **** -97 8 TTCTTTCCTGATCTATCGGTCACCTGGAACTTAAAGGTGCTTGGATCCATTTTCCAGCAG 
八 A A A A 








* * * * * * * * * -918 TCCTTGATCGACCTCGGCTCTTTCTTAAAGAAGGACCTGGGGGCGAGGAAGGAGGCGCTG 
A A A A A A 
MnlI Eco0109 MnlI HaeII 
SecI PpuMI MnlI 
SecI 
* • * * * 
-858 AAACACTTTTAAGTCTCTCCAGGGAACTGCCGCAGTCTCTAACCTTTCGTTCACACGCCC 
A A A 
BsmAI SecI BsmAI 
-798 TGATGGTGGCCATTGGACTTCGCTTCCCGGCAAGCCTCCGCAGACTGGCCTCACAGAGGG 
A A A A A 




* * * * 
-738 TCAGGTCTGGACTACTCCCCAGCATGCTTGGAGCTCATGGGCGATCCCGCCCCCTCAGTC 
A A A A A 






• * * • * 
-678 AATGGGGAGGATACGTCGAACTCCATTTCCCAGAACACACCAGGGCTCGCTGTGGCAACT 





«_ * * • • * 
-618 GCACTGAGGCCTTGGTGCTGACTACACTTCCCGGCAGGGACTGCGGCCCAGCGTACCTGG 
A A A ^ A 
EcoB EcoTl4I AlwNI MnlI 
HaeI 
S e c I 
S t u I 
S t y I 
136 
* 
- 5 5 8 AAAGAGGAGCGCGTAAACCTACTCCATTTCCTCGCCCATCTCCGGAACTGCAGTATCCAC 
/V A /V A 
M n l I A c c I I I P s t I S e c I 
B s m I I 
* * * * 
- 4 98 CTGGGGCTTAAAAACCACCTGAGACTCCATTTCCCGGCGTGCTTTAAAAATCGCTTTACA 
A A A A 
BsmAI DraI BspMI 
PleI 
- 4 38 CCTGCAATGCGGTGAGGGCGTGGCGACGACTCCATTTCCCGGCTTGCCTCACGGCCCGAG 
A A A A A /\ 
MnlIHphI PleI Mnll Aval 
BsmAI 
N s p I I I 
- 3 7 8 ACCCGCAGTTTCACGCGGGCCGACTCAATTTCCCAGAGCGCACCGGGCTCTGGGAGGCAT 





- 3 1 8 ACACAGCTAATAGACTGAGTGAGTGGACTCCGTTTCCCAGCGTGCATCAGGCTCTCTGCT 
A /V 
PleI SfaNI 
1630 1640 1650 1660 1670 1680 
* * * * * 
- 2 58 TCCTAAAGTGCTTCAGGGCTCCCCGTCGTATAGTCGGCTGACAGATTACCCTGGACTCCA 
AA A 




- 1 9 8 TTTCCCGACGTACAGCGTGACCCGTCATTCCCGCCCATCATTCCCGCGGTCTACTCTGAG 
A A A 
DsaI AccI 
NspBII MnlI 
S a c I I 
SecI 
- 1 3 8 GCTTTTGTGGACTTCATTCCCCGGCGTGCCACGCGGCTCTCTGTGCGGGCCGAGGGCGGT 
A A A A 
— SecI MnlI SecI HphI 
- 7 8 GACGGCGGCGCGGACGACAGCCGGACTGCATCTCCCGGCGTGCCCCGCGGCGGGCGCTGG 
A A A A A A 







* * • * * * * • * * 
-18 GCCGGAGCCGGAGCCTAAGCCGAGAGCGGCGCGGCCTGGAAGAGGCCAGGGCCCGGGGGA � A A /N A A /N /N A /S 
NlaIV NlaIV EarI HaeI ApaISecI 






N l a I V 
N s p I I I 
S e c I 
SmaI 
XmaI 
• • • * * 
+42 GGCGGCGGCAGCGGCGGCGGCTGGGGCAGCCCGGGCAGCCCGAGCCCCGCAGCCTGGGCC 
A AA /V A A A A A A A A 
BbvIEco52l BbvIAvaI BbvIAvaI BbvISecI 












Primers designed on GSK-3a promoter region: (From 5，to 3，） 
- 1 8 7 8 
5 ‘ CTGGCTTCCT TATTTTTGGC TTTCCGGGAT CTTGTAATTT AGGAAGCGGA 
3 , GACCGAAGGA ATAAAAACCG AAAGGCCCTA GAACATTAAA TCCTTCGCCT 
GGATGCAAAA CACAAGAGTG GGAGGCCCGG TGCCGTGGCT CAAGCCTGAA 
CCTACGTTTT GTGTTCTCAC CCTCCGGGCC ACGGCACCGA GTTCGGACTT 
ATACCAGCAC GTTGGAGGCT GAGGTAGAAT CGCTTGAGCC CAGGAATCGG 
TATGGTCGTG CAACCTCCGA CTCCATCTTA GCGAACTCGG GTCCTTAGCC 
AGACCGGCCT GGGCAACATG GCGAAGCCCA CCCCGCTACC CCCCACCACC 
TCTGGCCGGA CCCGTTGTAC CGCTTCGGGT GGGGCGATGG GGGGTGGTGG 
CCAAAAAACA AACCAAACCA AATTAGCTGG GCGTGATGGT GCACGCCTGT 
GGTTTTTTGT TTGGTTTGGT TTAATCGACC CGCACTACCA CGTGCGGACA 
AGTCCCACCT ACATGGGAGG CTTAGGTGGG GGGATTGCTT GAGCCTGGGA 
TCAGGGTGGA TGTACCCTCC GAATCCACCC CCCTAACGAA CTCGGACCCT 
G S K - 3 a P 7 
GTTAGAGGCT GCAGTGACCT GTGATTGCGC CACTGCCCGC CAGCCTGGGC 
CAATCTCCGA CGTCACTGGA CACTAACGCG GTGACGGGCG GTCGGACCCG 
GGCAGAGCGA GACCCTGTCT CAAAACAAAC CAAAAACTGA AAACTGAATG 
CCGTCTCGCT CTGGGACAGA GTTTTGTTTG GTTTTTGACT TTTGACTTAC 
G S K - 3 a P - l l 
GTGGTTCAAG ACAGGATTTT TTTTTTTTTG AGACGGAGTC TCACTCTTTT 
CACCAAGTTC TGTCCTAAAA AAAAAAAAAC TCTGCCTCAG AGTGAGAAAA 
CGCCCAGACT GGAGTGCAGT GGCGCGATCT CGGCTCACTG CAACCTATGC 
GCGGGTCTGA CCTCACGTCA CCGCGCTAGA GCCGAGTGAC GTTGGATACG 
CTCCCGGGTT CAAGCGATTC TCCTGCTTCA GCCTCCTGAG TAGCTGGTAT 
GAGGGC.CCAA GTTCGCTAAG AGGACGAAGT CGGAGGACTC ATCGACCATA 
TACAGGCGCC CGCCACCACA CCCGGCTAAT TTTTGTACTT TTAGTAGAGA 
ATGTCCGCGG GCGGTGGTGT GGGCCGATTA AAAACATGAA AATCATCTCT 
G S K - 3 a P 1 2 
CGGGGGTTTC GCTATGTTGG CCAGGCTGGT CTCGAACTCC TGACCTCGGA 
GCCCCCAAAG CGATACAACC GGTCCGACCA GAGCTTGAGG ACTGGAGCCT 
TGATCCGCCA GCCTCGGCCT CCCAAAGTGC TAGGATTACA GGCGTGAGCT 
ACTAGGCGGT CGGAGCCGGA GGGTTTCACG ATCCTAATGT CCGCACTCGA 
139 
ACTGGCGCCC AGCCTGAGCC ACAGTGCCAG GCCCAGAAAT GACATTTCCG 
TGACCGCGGG TCGGACTCGG TGTCACGGTC CGGGTCTTTA CTGTAAAGGC 
TCTTTTTAAT GCTCCATTCA GCTTCCTGGT GCGAACCACA TTGCTAGGAA 
AGAAAAATTA CGAGGTAAGT CGAAGGACCA CGCTTGGTGT AACGATCCTT 
G S K - 3 a P 9 
AAGCTAGACT GTATCCGAAG ACTAGTCAGT GTTCTGAGAA ACCGCCGGGA 
TTCGATCTGA CATAGGCTTC TGATCAGTCA CAAGACTCTT TGGCGGCCCT 
ACTTTGTTTC CCGAATCTTT GCAGAGTTGC GGTTAGAGAG GGGACATTTT 
TGAAACAAAG GGCTTAGAAA CGTCTCAACG CCAATCTCTC CCCTGTAAAA 
TTCTTTCCTG ATCTATCGGT CACCTGGAAC TTAAAGGTGC TTGGATCCAT 
AAGAAAGGAC TAGATAGCCA GTGGACCTTG AATTTCCACG AACCTAGGTA 
TTTCCAGCAG TCCTTGATCG ACCTCGGCTC TTTCTTAAAG AAGGACCTGG 
AAAGGTCGTC AGGAACTAGC TGGAGCCGAG AAAGAATTTC TTCCTGGACC 
G S K - 3 a P 1 0 
GGGCGAGGAA GGAGGCGCTG AAACACTTTT AAGTCTCTCC AGGGAACTGC 
CCCGCTCCTT CCTCCGCGAC TTTGTGAAAA TTCAGAGAGG TCCCTTGACG 
CGCAGTCTCT AACCTTTCGT TCACACGCCC TGATGGTGGC CATTGGACTT 
GCGTCAGAGA TTGGAAAGCA AGTGTGCGGG ACTACCACCG GTAACCTGAA 
G S K - 3 a P 8 
CGCTTCCCGG CAAGCCTCCG CAGACTGGCC TCACAGAGGG TCAGGTCTGG 
GCGAAGGGCC GTTCGGAGGC GTCTGACCGG AGTGTCTCCC AGTCCAGACC 
ACTACTCCCC AGCATGCTTG GAGCTCATGG GCGATCCCGC CCCCTCAGTC 
TGATGAGGGG TCGTACGAAC CTCGAGTACC CGCTAGGGCG GGGGAGTCAG 
AATGGGGAGG ATACGTCGAA CTCCATTTCC CAGAACACAC CAGGGCTCGC 
TTACCCCTCC TATGCAGCTT GAGGTAAAGG GTCTTGTGTG GTCCCGAGCG 
TGTGGCAACT GCACTGAGGC CTTGGTGCTG ACTACACTTC CCGGCAGGGA 
ACACCGTTGA CGTGACTCCG GAACCACGAC TGATGTGAAG GGCCGTCCCT 
CTGCGGCCCA GCGTACCTGG AAAGAGGAGC GCGTAAACCT ACTCCATTTC 
GACGCCGGGT CGCATGGACC TTTCTCCTCG CGCATTTGGA TGAGGTAAAG 
. G S K - 3 a P 2 
CTCGCCCATC TCCGGAACTG CAGTATCCAC CTGGGGCTTA AAAACCACCT 
GAGCGGGTAG AGGCCTTGAC GTCATAGGTG GACCCCGAAT TTTTGGTGGA 
GAGACTCCAT TTCCCGGCGT GCTTTAAAAA TCGCTTTACA CCTGCAATGC 
CTCTGAGGTA AAGGGCCGCA CGAAATTTTT AGCGAAATGT GGACGTTACG 
G S K - 3 a P 6 
GGTGAGGGCG TGGCGACGAC TCCATTTCCC GGCTTGCCTC ACGGCCCGAG 
CCACTCCCGC ACCGCTGCTG AGGTAAAGGG CCGAACGGAG TGCCGGGCTC 
140 
ACCCGCAGTT TCACGCGGGC CGACTCAATT TCCCAGAGCG CACCGGGCTC 
TGGGCGTCAA AGTGCGCCCG GCTGAGTTAA AGGGTCTCGC GTGGCCCGAG 
TGGGAGGCAT ACACAGCTAA TAGACTGAGT GAGTGGACTC CGTTTCCCAG 
ACCCTCCGTA TGTGTCGATT ATCTGACTCA CTCACCTGAG GCAAAGGGTC 
CGTGCATCAG GCTCTCTGCT TCCTAAAGTG CTTCAGGGCT CCCCGTCGTA 
GCACGTAGTC CGAGAGACGA AGGATTTCAC GAAGTCCCGA GGGGCAGCAT 
G S K - 3 a P 4 R e v 
TAGTCGGCTG ACAGATTACC CTGGACTCCA TTTCCCGACG TACAGCGTGA 
ATCAGCCGAC TGTCTAATGG GACCTGAGGT A A A G G G C T ^ ATGTCGCACT 
G S K - 3 a P 4 
CCCGTCATTC CCGCCCATCA TTCCCGCGGT CTACTCTGAG GCTTTTGTGG 
GGGCAGTAAG GGCGGGTAGT AAGGGCGCCA GATGAGACTC CGAAAACACC 
ACTTCATTCC CCGGCGTGCC ACGCGGCTCT CTGTGCGGGC CGAGGGCGGT 
TGAAGTAAGG GGCCGCACGG TGCGCCGAGA GACACGCCCG GCTCCCGCCA 
GACGGCGGCG CGGACGACAG CCGGACTGCA TCTCCCGGCG TGCCCCGCGG 
CTGCCGCCGC GCCTGCTGTC GGCCTGACGT AGAGGGCCGC ACGGGGCGCC 
G S K - 3 a P l 
+ 1 AN1 
CGGGCGCTGG GCCGGAGCCG GAGCCTAAGC CGAGAGCGGC GCGGCCTGGA 
GCCCGCGACC CGGCCTCGGC CTCGGATTCG GCTCTCGCCG CGCCGGACCT 
^ A ~ 
AGAGGCCAGG GCCCGGGGGA GGCGGCGGCA GCGGCGGCGG CTGGGGCAGC 
TCTCCGGTCC CGGGCCCCCT CCGCCGCCGT CGCCGCCGCC GACCCCGTCG 
CCGGGCAGCC CGAGCCCCGC AGCCTGGGCC TGTGCTCGGC GC 3丨 





Hu GSK-3 alpha •> Full Restriction Map 
DNA s e q u e n c e 2169 b . p . GCCAGAGCGGCG …TTGGCATGAAAA l i n e a r 












Sau96 I Scr? I 
Sau96 I � I 
N l a IV ^-^P I 
Bspl286 I Kpa. II 
ScrF I 3an II � I 
EcoR II Sec I Hpa II ^ ^ I 
EcoN I ScrF I Sraa I" 
Hae III EcoR II Sec I 
Fnu4H I Hae III 3cn I • P „ „ �了 " ^crF I 
BstU I Mnl I Apa I FnuI^? =ci I 
HinP I Kbo II Eco0109 I Nsna ri Bcn I 
Fnu4H I BstN I Hae .1 Hae III =.^ ,,7S ； Ava I Ava I 
3gl I Hha I AN-iEar I BstN I Kni r 1." ? � ” Fnu4H I Fnu4H I 
I , I I I I J I l r n r I III II ， l I ?，,I | fnu4HI 3bv I 3bvi 
GCCAGAGCGGCGCGGCCTGGAAGAGGCCAGGGCCCGGGGGAG&GACGi<Uicc^ rJ>rr^ _^^ J<o 丨丨.‘‘ 
� G T C T ^ G C - C ^ C p C Y l f ^ C ^ f O C C C C p G c g S g ^ g S ^ ^ C ^ J ^ c g ^ G ^ G e C ^ = 30 
1 7 1 � . 2 � 2 , 31 .0 !厂 I ^3- ^ 7 . " ;s I 
10 20 29 L 67 76 
11 23 30 „ 71 80 
12 25 34 “ „ 71 
14- • 27 “ 71 
16 27 n 
16 27 34 71 
16 30 71 
3Q 71 
- 30 72 
30 72 
31 72 





Hha I Sec I 
Nla IV ScrF I 
Hae III Nax L EcoR II 
_ Sec I Hae II 3stN I 
ScrF I Bbe I Bgl I Espl286 I 
Fnu4H I Ban I EcoN I Sau96 I 
Bbv I Sau96 I Aha II Fnu4H I Hae III 
B s p l 2 8 6 I EcoR II HgiA I Fnu4H I Hae III Fnu4H I Ban II 
Ban 11 BstN I Bspl286 I Nla III Sau96 I Mnl I Sec I Ava I 
I I I II I 丨丨 . 1 I . ' , . 丨 丨 > , . I , I . " I I , 1 . 丨 . , . 
CCGAGCCCCGCAGCCTGGGCCTGTGCTCGGCGCCAT^GC!2Gq3GC.GGGCCT|TCQGG^GqGGQCCTGGG<;GCTCGGGqA 160 
GGCTCGGGGCGTCGGACCCGGACACGAGCCGCGrGTACtCGCCGCCGCCCGGAAGCCCTCCGCCGGGACCCCCGAGC'cCGT 
I ’ I I I I • I I I I I • I I I I I I I I I 1 ‘ I I . 
83 94 103 114 127 137 144 153 
83 94 103 119 128 140 150 
90 97 109 122 142 
90 109 130 142 
94 109 143 150 
94 109 145 





• ScrF I 
Nci I 
Msp I Bcn I 
ScrF I Sec I 5gl I 
Nci I Sau96 I Sau96 I 
Bcn I Nla IV Hae III 
Bspl286 I Kae III Msp I 
BstU I Ban II Fnu4H I Bgl I Hpa II 
HinP I Alu I Nla IV Fnu4H I Mnl I Fnu4H I Kpa II Knl I 
Hha I Mae I BsCU I Hpa II Mnl I Mnl I Fnu.4H I Mnl I Hae III Sec I 
II . , I I . I, II II . I . . I . . I , I I I I l l l l l I I I I I I I 
GqGCGtGGACTjAGCTCGT.TCGCG.dAG.CCCGGqGGC,GGAGGCGGAGGAGGCGGCGGCGGCCCCGGAGGCTCGGCCTCCGGC 2 4 0 
CCCGgGCCTGATCGAGCAAGCGCCTCGGGCCGCCGCCTCCGCCTCCTCCGCCGCCGCCGGGGCCTCCGAGCCGGAGGCCG 
.I I I I I I I I I • I I • I 1 I • I I I I I I I I • 1 I I 1 I I 
163 170 180 188 197 206 215 224 231 240 
163 172 183 191 203 212 221 233 
164 184 209 218 236 
184 217 236 
187 217 233 
187 217 238 









- Taq I 
Nla III Xho I Sec I Msp I 
Sty I Pa^J^7 I" Kpa II 
• Nla IV '. Sec I Ava I ScrF I ScrF I 
Ban I Nco 工 Sau96 I Nci I Nci I 
Fnu4H I Fnu4H I Psa_ I Nla IV 3an II Bcn I 
ScrF I Msp I Hae III Eco0109 I Msp I Sau96 I 
EcoR II Hpa II Sau96 I Hoa T Mnl l Hpa II Nla IV 
BsUN I CfrIO I SfaN I Nla IV Aha II Hae III Bcn I Ava II 
I I I I I I I I I I 1 I I I I I I 1 I I I I 1 I I I 
CCAGGCGGCACCGGCGGCGGAAAGGCATCTGTCGGGGCCATGGGTGGGGGCGTCGGGGCCTCGAGCTCCGGGGGTGGACC 3 2 0 
GGTCCGCCGTGGCCGCCG^:CITTdCCTiAGACAGCCCCGGTACCCACCCCCGCAGCCCCGGAGCTCGAGGCCCCCACCTGG 
I I I 1 1 I • 1 . • I I I I I • I I 1 I I I I I I I I • 1 I I 
241 250 '2-265 274 289 297 308 316 
241 251 275 290 299 308 316 
241 251 276 295 308 316 
245 254 278 295 303 319 
247 278 296 308 319 
247 278 300 308 319 
278 300 - 320 









HinP I Nci I 
Msp I Msp I 
Hpa II Hpa II 
S c r F I Bcn I 
Nci I Xma I 
Sau96 I Sma I 
Nla IV Sec I 
Fnu4H I Hae III ScrF I 
NspB II Fnu4H I Bcn I Nci I 
Fnu4H I Bbv I Eco0109 I Bcn I Hae III 
Bbv I Mnl I Mnl I Hha I Alu I Ava I Alu I Mae III 
Fnu4H I Mnl I NspB II Sec I Mae I Fnu4H I Hph I Sau96 I 
I I I 1 I 1 1 I I 1 I I I 1 I I 1 I I I I 1 I 1 1 
CGGCGGCAGCGGCGGAGGAGGCAGCGGAGGCCCCGGCGCAGGCACTAGCTTCCCGCCGCCCGGGGTGAAGCTGGGCCGTG 4 0 0 
GCCGCCGTCGCCGCCTCCTCCGTCGCCTCCGGGGCCGCGTCCGTGATCGrAGGGCGGCGGGCCCCACTTCGACCCGGCAp 
I I I I . I I • I I I I I • I I 1 I • I I • I 1 I I I . I I I .. 
323 335 342 351 365 375 384 393 
326 338 347 356 3 67 379 3£9 398 
326 341 348 379 394 
327 341 352 379 










HinP I ‘ 
Sty I Hha I 
Sec I Hae II 
Mae III Hae III Ico47 J H 
Hph I Hae I Sau96 I 
Nsp3 II BstLE 11 Mae I Hae III PflM I 
I I I I I 1 I I I I 1 
ACAGCGGbAAC.GTGACCACAfi3:£GTAqtcACTCTAGGCCAAGGCCCAGAGCGCTCCCAAGAAGTGGCTTACACGGACATC 4 8 0 
TGTCGCCCTTCCACTGGTGTCAGCATCGGTGAGATCCGGTTCCGGGTCTCGCGAGGGTTCTTCACCGAATGTGCCTGTAG 
I . I I • • I I I I • I I I I . . . 
402 4 1 1 433 442 456 
411 435 442 





ScrF I ScrF I 
EcoR II EcoR II 
BstN I BstN I Mae I 
Rsa I BsmA I Spe 1 
I I I I I I 
AAAGTGATTGGCAATGGCTCATTTGGGGTCGTGTACCAGGCACGGCTGGCAGAGACCAGGGAACTAGTCGCCATCAAC^J^ 560 
TTTCACTAACCGTTACCGAGTAAACCCCAGCACATGGTCCGTGCCGACCGTCTOTGT-CCOTGATCAGCGgrAGTOTT 
. - . • I I • • I I . I I . . 
513 532 543 
516 536 544 
", 516 536 




ScrF I Pst I 
EcoR II Fnu4H I Sau96 I 
BstN I Bbv I Nla III Ava II Dde I 
• Gsu I Mnl I Alu I Dpn I Alu I Ssp 1 Mnl I 
1 1 I I I 1 1 1 — 1 1 1 I 1 
GGTTCTCCAGGACAAGAGGTTCAAGAACCGAGAGCTGCAGATCA'TUCGTAAGCTGGACCACTGCAATATTGTGAGGCTGA 6 4 0 
CCAAGAGGTCCTGTTCTCCAAGTTCTTGGCTCTCGACGTCTAGTACGCATTCGACCTGGTGACGTTATAACACTCCGACT • 
I I . I . • ！ 1 I I I • I I • I • I I . 
565 576 593 600 611 625 633 
567 594 603 615 637 






Bsr I ‘ Ava I 
Gsu I Mbo II Alu I Bspl286 I Rsa I 
1 1 1 I I I I 1 
GATACTTTTTCTACTCCAGTGGCGAGAAGAAAGACGAGCTTTACCTAAATCTGGTGCTGGAATATGTGCCCGAGACAGTG 7 2 0 
CTATGAAAAAGATGAGGTCACCGCTCTTCTTTCTGCTCGAAATGGATTTAGACgACCACCrTmCACGgGCTpTGTCAC 
. 1 I . I • I • • • I I • I 1 
654 666 677 706 720 
656 • 709 712 
Sau96 I 
Hae III Rsa I 
ScrF I Nla III 
Nci I Hae I NSPH I 
Msp I Sty I Nsp7524 1 Mbo II 
Hpa II Sec I HinC II tU. JJJ： Ear I 
Bcn I Hph I Hae III Fok I Hnl I Rsa I Alu I 
1 I I I I I I 1 I 1 I 1 I I 1 I 
TACCGGGTGGCCCGCCACTTCACCAAGGCCAAGTTGACCATCCCTATCCTCTATGTCAAGGTGTACATGTACCAGCTCTT 800 
ATGGCCCACCGGGCGGTGAAGTGGTTCCGGTTCMCTGGTAGGGATAGGAGATACAGTTCCACATGTACATGGTCGAGAA 
I I . I I I I • 1 I • I • • I 1 . 1 I • I I I • 
723 740 747 759 768 783 794 
723 743 753 785 796 




729 ‘ Sec I 
Hae I ScrF I 2 r i I 
Alu I EcoR II BstU I Sau96 I 
Fnu4H I Fok I BscN I Hph I BspM I Nla IV 
Bbv I Hae III Sec I Mae III M^^I I Ava II 
I 丨 I I 丨 I I I I I I I I I 
CCGCAGCTTGGCCTACATCCACTCCCAGGGCGTGTGTCACCGCGACATCAAGCCCCAGAACCTGCTGGTGGACCCTGACA 880 
GGCGTCGAACCGGATGTAGGTGAGGGTCCCGCACACAGTGGCGCTGTAGTTCGGGGTCTTGGACGACCACCTGGGAC^X3T 
1 1 I I I . I 1 • I I • 1 • I I I I • 
803 810 824 836 856 870 
803 816' » 825 837 860 870 
805 825 841 870 
809 825 877 
825 
Mnl I 
Sec I Bspl286 I 
Alu I Sau96 I Ban II 
Mnl I Ava II Nla IV BsmA I 
1 1 � I 1 I I I I 
CTGCTGTCCTCAAGCTCTGCGATTTTGGCAGTGCAAAGCAGTTGGTCCGAGGGGAGCCCAATGTCTCCTACATCTGTTCT 9 6 0 
GACQACAGGAGTTCGAGACGCT;^AAACCGTCACGTTTCGTCAACCAGGCTCCCCTCGGGTTACAGAGGATGTAGACAAGA 
I . I • • • I I I • I I • I • • 
888 924 933 943 















ScrF � Alu I 
Nci I sac I A l u � 
Msp I . HgiA I Taq I Pvu II 
Hpa I I B s p l 2 8 6 I Fok I T t h l l l I I 
Bcn I Ban II Nla IV Mnl I £1^ I Nsp3 Ii Rsa I 
I II 11 丨 丨丨 丨丨丨 U I 
rrrTACTACCGGGCCCCAGAGCTCATCTTTGGAGCCACTGATTACACCTCATCCATCGATGTTTGGTCAGCTGoCVGTGT 1 0 4 0 
g^i?^GATGGCCCGGGGTCTCGAGTAGAAACCTCGGTGACTAATGTGGAGTAGGTAGCTACAAACC?im:G^CCG/._Ci^  
1 . I I 1 I • I • I I I 1 I I I • I • 
969 979 991 1007 1015 1028 1039 
9 5 9 979 1010 1020 
5gg 979 1016 1023 











Mnl I Sec I Alu I 
Alu I ScrF I Pvu II 
Sac I EcoR II NspB II 
HgiA I . BstN I PflM I Sau3A I 
Bspl286 I Hae III Sec I Sau96 I Mbo I 
Bsr I Ban II Sau96 I Mbo II Ava II Dpn I 
r I 1 I I I I I I 1 I 1 1 I 
^CTGGCAGAGCTCCTCTTGGGCCAGCCCATCTTCCCTGGGGACAGTGGGGTGGACCAGCTGGTGGAGATCATCAAGGTGC 1 1 2 0 
TGACfGTCTCGAGGAGAACCCGGTCGGGTAGAAGGGACCCCTGTCACCCCACCTGGTCGACCACCTCTAGTAGTTCCACG 
1 I I ^ . � 1 � I 1 I • • I I I I • ‘ • • 
i04i 1043 1059 1070 1092 1107 
1048 1060 1074 1092 1107 
1048 1075 1095 1107 
1048 1075 1096 
1049 1075 1096 
1053 1075 1097 










Bcn r Dde I Alu I 
Ava I’ Mnl I. Mse I Hph I 
I I I I I I I 
T G G G A A C A C C A A C C C G G G A A C A A A T C C G A G A G A T G A A C C C C M e 3 M A C S 5 ^ C T 5 M 5 T T C C C T C A G A T T A A A G C T C A C 1 2 0 0 
ACCCTTGTGGTTGGGCCCTTGTTTAGGCTCTCTACTTGGGQTrQA3:S3:SCCTCAAGTTCAAGGCAGTCTAATTTCGAGTG 
. I I . . • • • I 1 I I 1 • 
1133 1183 1190 1197 










1 1 3 4 . 
146 
ScrF I " � I 二 TT Hae I Hha I 
i m I Fnu4H I Hae I I I Rsa I Mnl I 
"^ T Taq I Mnl I BscU I Mae I Gsu I Fok I 
f r I I 111 11 I I I 1 I 
rrrTGGACAAAGGTGTTC ;^AATCTCGAACGCCGCCAGAGGCCATCGCGCTCTGCTCTAGCCTGCTGGAGTACACCCCATC 1 2 8 0 
SGACCTGTTTCCACAAGTTTAGAGCTTGCGGCGGTCTCCGGTAGCGCGAGACGAGATCGGACGACCTCATGTGGGGTAG 
1 I . . I 1 I I I • I 1 • I • 1 I • I I 
i n i 1224 1237 1 2 4 5 1256 1264 1277 
1 2 0 2 1230 1239 1269 1280 
J 2 0 2 1238 1246 
1202 1246 
Hae III Fnu4H I 
£LU I Alu I 
.Hae I Hin? I ?vu II 
Mnl I Kha I Nsp3 II 
Kae I = ^ I Alu I Kla IV =bv I 
1 I I I I I I I 1 � 1 1 I 
CTCAAGGCTCTCCCCACTAGAGGCCTQIGCGCACAGCTTCTTTGATGAACTGCGATGTCTGGCAACCCAGCTGCCTAACA 1 3 6 0 • 
GAGTTCCGAGAGGGGTGATCTCCGGACACGCGTGTCQt t JvGAAACTACTTGACGCTACAGACCCTTGGGTCGACGGATTGT 
. I I I 1 I I • 1 • • • 1 I I I • 
1297 1308 1315 1342 1350 
1 3 0 0 1309 1348 
1 3 0 1 1309 1348 
1301 1349 
1302 1350 
Mbo I I 
Ear I • Mme I Mnl I 
Mnl I Rco57 1 Hph I Fok I BsmA 1 Fok I 
1 I I 1 1 I I I I I 
ACCGCCO^CTTCCCCCTCTCTTCAACTTCAGTGCTGGTGAACTCTCCA3:C^AACCGTCTCTCAACC^CATTCTCATCCCT 1 4 4 0 
TGGCGGGTGAAGGGGGAGAGAAGTTGAAGTCACGACCACXTGAGAGGTAGGTTGGCAGAGAGTOCGGTMG;^.GTAGGGA 
. I 1 1 . I • I • I I • * • • I I • 
1375 1386 1396 1407 1416 1434 




Ava I I P i e I 
PpuM I Fnu4H I Mse I Hinf I 
E c o 0 1 0 9 I Hph I EiJQi2 UJL BsmA I Dde I 
MnI I Mnl I NspB II Mnl I Knl I Alu I Dde I Kme I Alu I 3sr I 
I 111 I I I I 1 11 i i I I I I I I 
CCTCACTTGAGGTCCCCCAGCGGCACTACCACCCTCACCCCGTCCTCACi^^GCTTTMCTGAGACTCCGL^CCAGCTCAGA 1 5 2 0 
GGAGTGAACTCCAGGGGGTCGCCGTGATGGTGGGAGTGGGGCAGGAGTGltrCCAAArrGALTCTGAGGCTGGTCGAGTCT 
I I I 1 I I . I I • I I 1 1 I • 1 I I • I I I 
1 4 4 1 1 4 4 9 1458 1473 1 4 8 4 1491 1499 1506 1513 1520 
1 4 5 0 1475 1490 1501 1515 
1 4 5 0 1 4 6 0 “‘ 1495 1503 
1 4 5 1 1503-
1 4 5 1 
1 4 5 1 
Sau96 I 
” Nla IV 
Hae I I I 
Sau96 I 
.• Nla IV. 




Taq I Mnl I 
S ^ 1 Dde I 
HinC II SSi:36 1 Tthlll II 
Acc I SfaN I Mnl I Mnl I Eco0109 I Nla IV 
I I I I 1 1 I 1 I I I I I 
C T G G C A G T C G A C C G A T G C C A C A C C T A C C C T C A C T A A C T C C T C d T G A f 3 G G C C C C A C C A A G C A C C C T T C C A C T T C C A T C T G G 1600 
GACCGTCAGCTGGCTACGGTGTGGATGGGAQTGAT2^^QC;AGQAea:CCCGGCGTGGTTCGTGGGAAGGTGAAGGTAGACC 
I I . 1 . I • 1 • 1 I 1 1 I I • ‘ I • • I 
1527 1534 1543 1559 1566 1600 
1527 1562 1576 



















ScrF I Nla IV 
Hae III EcoR II Mae I 
6 I Sau96 I BstN I Hae III Mnl I 
^ n i i Mnl I Nla IV Alu I Sec I Apa I Mae I . Mnl I,, 
, " “ I I I I I I I I I I I 1 1 • 
rArrCCCAAGAGGGCGTGGGAAGGGGGGCCATAGCCCATCAAGCTCCTGCCCTGGCTGGGCCCCTAGACTAGAGGGCAGA 1680 • 
CTCGGGGTTCTCCCGCACCCTTCCCCCCGGTATCGGGTAGTTCGAGGACGGGACCGACCCGGGG^^TCTGATCTCCCGTC^ 
I I . I I 1 . • I 1 I I I • I I • I 1 • 
601 1610 1625 1642 1650 1658 1669 1679 \ll； 1626 1651 1659 1672 








Bsr I Hph I 
p]_e I Gsu I Mnl I Hph I Mnl I 
Hinf I Mnl I Mnl. I Mnl I Mse I Mse I 
I I I 1 I I I I I I I I • 
G d T A A A T G A G T C C C T G T C C C C A C C T C C A G T C C C T C C C T C A C C A G C C T C A C C C C T G T G G T G G G C T T T T T A A G A G G A T T T T A 17 6 0 
CCATTTACTCAGGGACAGGGGTGGAGGTCAGGGAGGGAGTGGTCGGAGTGGGGACACCACCCGAA;^AATTCTCCTA>J^JvT 
1 . . I I I • I I I • I I • • I • I I • 
1688 1703 1712 1725 1747 1758 
1688 1704 1716 1727 17S1 
1706 1718 
Ssu96 I • 
Ava II Sau96 I • 
PpuM I Nla IV 
Mbo II Eco0109 I Hae III 
Ear I Mnl I Scy I Mnl I 
Rqr T Mnl I Fok I Mnl I Sec I Knl I 
r j I . I I 1 I I I I I I 
A C T G G T T G T G G G G A G G G A A G A G A A G G A C A G G G T G T T G G G G G G A T G A G G A C C T C C T A C C C C C T T G G C C C C C T C C C C T C C C C 18 4 0 
TGACGAACACCCCTCCCTTCTCTTCCTGTCCCACAACCCCCCTACTCCTGGAGGATGGGGGAACCGGGGGAGGGGAGGGG 
, . 1 I . . • I I I I 1 I I I • I • 
i7gi 1773 1801 1810 1820 1829 
1777 1805 1820 1834 





Gsu I 如 I 
Mnl I • Knl I Mnl I 
Mnl I Mnl I Mnl I T ^ \ ] \ 
CAGAicTCCAicTiiTCCAGAdcCCCTCCCCTCCTGTGTCcbTTCTAAATAGAACCAGCCCAGCfCCGTCTCCTCTTCCCT 1920 
GTCTGGAGGTGGAGGAGGTCTGGGGGAGGGGAGGACACACpGAAgAXTTiLTQrG2a:CGQG_TCQGGCA(^GG;AGAAGpqA 
I . 1 I 1 . I I • • • ‘ • I I 1 * 
1845 1854 • ‘ 1865 1907 




















ScrF I Hpa II 
EcoR II „ Hl?r I 
BstN I Bcn I Taq I =spM I 
Sec I sec I Wse I iia± 71 l^ r.e I 
I I 丨 I I I 1 丨丨丨 I ' 
TCCCTGGCCCCCGGGTGTAAATAGATTGTTATAATTTTTTTCTTAAAGAAAACGTCGATTCGCACCGTCCAACCTGCCCC 2000 
AGGGACCGGGGGCCCACATTTATCTAACAATATTAAAAAAAGAATTTCTTTTGCAGCTAAGCGTGGCAGGTTGGACGGGG 
I 1 I I I 1 . • • I • I I I • I • I • • 
1922 1929 1963 1972 1S88 


















Gsu I ScrF I 
Mae III ScrF I EcoR II 
Alu I Acc I Hph I EcoR II BstX I 
pvu II Sty I Knl I BscN I BstN I 
Mnl I NspB II Mnl I Mnl I Sec I Mnl I Sec I Sau96 I 
I I I I I I 1 1 I I I 1 1 1 I 1 I I 
GCCCCTCCTACAGCTGTAACTCCCCTCCTGTCCTCTGCCCCCAAGGTCTACT.CCCTCCTGXCCCCACCCTGG^.GGGCCAG 2080 
CGG.GGAGGATGTCGACATTGAGGGGAGGACAGGAGACGGGGr,TTCCAGATGAGGGAGGAGTGGGGTGGGACCTCCCGGTC 
.,. .1 I I - . I . I • I I • I I I • I I I • I I I I • 
2004 2011 2024 2032 2041 2054 2067 2074 
2011 2041 2057 2068 2077 
2012 2046 2059 2068 2077 
2016 2068 2077 
- 2069 2077 
2072 
2075 
. r 2077 
Alu I 
Sac I 
HgiA I . 
Bspl286 I 
Ban II Dde I Rsa I Mnl I 
I I I I I 
GGGAGTGGAGAGAGCTCCTGATGTCTTAGTTTCCACAGTAAGGTTTGCCTGTGTACAGACCTCCGTTCAATAAATTATTG 216 0 
CCCTCACCTCTCTCGAGGACTACAGAATC;^J>j^t;GTGlt:ATTCCAAACGr^CACATGTCTGGAGGCMGTTATTTAATAAC 
. I I • I • • I I • • 














pUC 18 Cloning Vector 
396 455 
3CCAAGCTTGCATGCCTGCAGGTCGACTCTAGAGGATCCCCGGGTACCGAGCTCGAATll 
I——I I ~ ~ T I——I » 4 丁 丨 」 f - ^ 
^^^^^^"^^^~i ^ ^ 遍 ^ ^ : ^ ^ ; : r ^ ^ ^ ^ ^ 
A.CC I Sma I 
-^ ____WmcH___^ Xma I 
Narl ^ 遍 
Hae II (235)*/f|g^Mi^ 
U ^ ^ ^ ^ ^ ^ " ^ ^ ^ ^ / • “ (680)* 
—109 I ( 2 6 7 4 � ^ / ^ ^ ^ ^ ¾ ^ ^ Afl III (806) 
Aani(26lV^y ‘ p B R 3 2 2 o r i 
55/?I(250n 
� pUC 18 
L 2 6 8 6 bp — Haell (1050)* 
/ \ A/wNI(1217) j 
/ 
• ^ ^ 
C/rlOI 
*Site not unique 
150 
pCAT®3-Basic Vector 
y ^ ^ ^ ' ^ ^ S ^ ^ on Synthetic poly(A) signal and 
X y ^ N ^ ^ transcriptional pause site 
S ^ X \ y (for background reduction) 
/ K ^ ^ ^ ^ ^ ^ slc\ 11 
p C A T ® 3 - B a s i c H < ^ : ; ; ; 
V e c t o r \ \ ^ Sma I 28 
" … … I \ Xho I 32 
I (4047) 广 _ ^ 7 6 柳 36 
kr i ( — M ， m u H i i ) 53 
/ r Nco I 309 \ J _ _ _ I j 
A ^ ^ ^ 
— p C J f ^ 
~";77"i 1 � S V 40 I 
^“11131 latepoly(A) Xba\91\ 
region 
-Sequence reference points: 
a. SV40 Promoter (none) 
b. SV40 Promoter directed transcriptional start sites (none) 
c. enhencer (none) 
d. SV40 late poly(A) 1001-1222 
e. CAT gene 311-967 
f. chimeric intron 102-234 
g. upstream poly(A) region 3887-4040 
h. multiple cloning site 1-58 
i. RVprimer3 binding site 3989-4008 
j. RVprimer4 brnding site 1309-1290 
k. p-lactamase (Amp') coding region 3169-2312 
1. f l origin 3302-3756 
m. ColEl-derived plasmid replication origin 1547 
-Additional description:八’ chimeric intron; CAT, gene encoding the 
chloramphenicol acetyltransferase gene; Amp', gene conferring ampicillin resistance 
in E.coli.’ f l ori, origin of replication derived from filamentous phase; ori, origin of 
plasmid replication in E.coli., Arrows within CAT and the Amp' gene indicate the 
direction of transcription; the arrow in f l ori indicates the direction of ssDNA strand 




5'GTA ATA CGA CTC ACT ATA GGG CAC GCG TGG TCG ACG GCC CGG GCT GGT3’ 〕 u i A r t i A 3,_H^N-CC CGAC CA-PO4-5' 
/ ^""""V 
Adaptor p r — r 1 (API) \ 
5'CCA TCC TAA TAC GAC TCA CTA TAG GGC3' \ 
Nf*ftf^ ariaptor primer 2 (AP2) 
5'CTA TAG GGC ACG CGT GGT3' 
Marathon cDNA Adaptor: 
c>CTA ATA CGA CTC ACT ATA GGG CTC GAG CGG CCG CCC GGG CAG GT3' 
) ^ 3'H2N-CCC GTC CA-PO4-5 
^ • 4 = ^ " " ~ { 
Arfqptor primer 1 (API) \ 
5'CCA TCC TAA TAC GAC TCA CTA TAG GGC3' \ 
Nested adaDt9r primer 2 (AP2) 
^ 5,ACT CAC TAT AGG GCT CGA GCG GC3' 
152 
Appendix VIII 
Anti-GSK-3 antibody: (Upstate Biotechnology, catalog 
no. 05-412) 
• clone 4G-IEm monoclonal 
• antigen specificity: 
peptide (CKQLLHGEPNVSYICSRY) 
residues between 203-219 of DrosphiUi GSK-3/shaggy 




Raw data of GSK-3a promoter activity assay: 
1. CAT ELISA 










































2. p-GAL ELISA: 
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